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The aim of this study was to test short-term and long-term reliability of venous 
outflow (VO) indices using the venous occlusion plethysmography technique. A 
secondary purpose was to compare venous measures to age, gender and various 
anthropometrical measures. The study group consisted of apparently healthy males and 
females, aged 18 to 80 years. Venous indices were under measures on two occasions (1 
week apart), under the conditions of rest and following 5 min of upper arm occlusion. 
Venous outflow measures were calculated from the area under the curve (AUC) as well 
as the plethysmographic curve technique at the time .5 (VO.5), 2 (VO2) and the time 
interval between .5-2 seconds (VO.5-2). Venous capacitance (VC) was calculated by 
measuring the distance in mm from the baseline to the maximum height of the inflow 
curve and dividing this distance by the height of the calibration mark. Intraclass 
correlation coefficient (ICC) revealed higher within-day reliability than one-week 
reliability for markers:  ICC’s =  .931 vs. .622, .948 vs. .709, .965 vs. .518, and .971 vs. 
.431 for VC, VO.5, VO2 and VO.5-2, respectively. One-week reliability for these measures 
following occlusion were: ICC’s = .562, .701, .646 and .639 for all indices. Pearson 
correlation revealed associations between VO.5 and VO2 with arm length (R= -.344, p< 
.09; R= -.430, p< .03), respectively. Age was associated with VO.5-2  (R = -.340, p< .10). 
In addition, there were gender differences in VC (p< .009). Finally, a stepwise regression 
analysis was performed showing significant predictive value of venous measures, in 
relation to body size, with arm length (F= 4.979, p< .03) and gender (F= 7.862, p< .01). 
Short-term VO measures showed stronger reliability than long-term measures. 
 v 
Additionally, it appears that vessel length and gender have an important influence on 









The venous system is a vast network of vessels that play a critical role in 
homeostasis. One of the primary roles of the venous system is that of capacitance. That 
is, the venous system serves as a reservoir of blood upon which the cardiovascular system 
can draw at times of increased demand for arterial blood delivery to active tissue. At rest 
the venous system typically accounts for 65% of the total blood volume, and is 
influenced by several factors including nutritional status, pharmacologic intervention, 
morbidity of various disease states, and emotional or physical arousal (e.g. physical 
activity, exercise). Invariably, it is this latter determinant, physical exertion that has a 
profound influence on venous function. During exercise, venous return increases, thereby 
facilitating increases in cardiac output, and shifting a greater percent of blood volume to 
the arterial side.  
While the importance of venous return on cardiac output for the purpose of 
enhanced delivery of oxygen and other humoral factors is well documented, the venous 
system also plays a crucial role in the removal of blood and waste products from 
exercising muscle. This removal of metabolic by-products plays a potentially important 
role in sustaining physical activity over long periods. This aspect of venous return has, 
for the most part, been underinvestigated with respect to exercise tolerance. and therefore 
functional ability. Yet, it may be of particular relevance with respect to function in 
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patients such as those with congestive heart failure (CHF), hypertension, chronic venous 
insufficiency (CVI), and peripheral vascular disease (PVD).    
Despite the lack of success with these approaches, the potential role of venous 
dysfunction in patients with diseases mentioned above has been largely unexamined. It is 
unclear what role the venous system may play in the underlying causes associated with 
many of these diseases. Therefore, efforts directed at unveiling the role of venous system 
function in the appearance of functional limitations imposed by signs and symptoms of 
cardiorespiratory limitations may assist in developing improved treatment strategies for 
cardiovascular-related conditions. Such treatment strategies have focused on arterial 
dysfunction, without regards to these effects on venous dysfunction. Therefore, the role 
of the venous system has been, to a large extent underestimated and underinvestigated, in 
its role concerning cardiovascular disease. The success of systemic investigation of 
venous function hinges on the availability of valid measurement techniques. An 
important characteristic of the validity of a measurement technique is its reliability.  
Overall reliability of the SGP method has been reported to range from 6% to 28% 
(Corbally & Brennan, 1990; LeJemtel, Katz, Jondeau & Solomon, 1992). One particular 
study conducted by Pallares, Deane, Baudouin and Evans, 1994, found SGP, when used 
to measure blood flow within-day measures at rest and during conditions of increased 
cardiac output, to be highly reproducible compared to Doppler ultrasound (0.45 and 0.94 
ml\100ml-1 tissue\ min-1 respectively). Additionally, studies conducted by Romano and 
Gizdulich, 1980; Altenkirch, Fransson and Koch, 1989, as well as Altenkirch, Koch and 
Koralewski, 1990, have found the SGP technique to be more reproducible for within-day 
measures than between-day measures. Accordingly, long-term reproducibility of 
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measures has not been well established, with the limited data available raising some 
question as to the long-term stability of these readings. Gizdulich and Michelutti, 1983, 
suggest that venous outflow measures may be influenced by venous occlusion pressure, 
and less by muscular tone, flow sampling rate and the length of the venous occlusion.  
The purpose of this study was to examine venous vascular function using EC-5R 
plethysmography system (Hokanson, Sumner & Strandness, 1999). More specifically, the 
objective of this study was to evaluate the reliability, using strain gauge plethysmography 
(SGP), of forearm blood flow during rest and immediately following ischemia.   
1.2 Clinical Significance  
 The venous system serves many important functions in the body such as selective 
barrier function, angiogenesis, postcapillary resistance, synthesis of bioactive substances 
and more importantly, a conduit or collection system with one-way valves that help 
regulate the distribution of blood volume. Due to the distensibility of veins, the venous 
side contains 65% of the total blood volume at rest and during activity is crucial for the 
removal of blood and waste products from exercising muscle. The perfusion of muscle 
tissue as well as the removal of by-products is therefore an important aspect in 
organ\system performance (Wecht et al., 2000). Several factors influence venous function 
including diet, exercise, disease, and pharmacotherapy (Rizzi et al., 1998). However, in 
comparison to arterial inflow, relatively few studies have examined venous function. The 
majority of data, although scarce, have examined the reproducibility of SGP in healthy 
young individuals at rest and following ischemia (Wecht et al., 2000). Despite the lack of 
consensus regarding the stability of the venous measures obtained from SPG, it is still 
used for the evaluation of blood flow due to its simple and economical method, and the 
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potential exists for SGP to contribute to our understanding of venous function. However, 
before this technique can be employed to evaluate the efficacy of various treatment 
strategies on venous function, more work must be done to establish the reliability of this 
technique and to identify potential sources of variation on venous function. To this end, 
venous system structure and function in health and disease states was reviewed in order 
to more fully understand the potential sources of variation on venous function. The 
methods section that followed included a presentation of the evidence regarding the 




Venous System  
 
 
2.1 Structure and Function of Veins    
 
The blood vessels of the body form a closed delivery system that begins and ends 
at the heart. If stretched out in a line, the 100,000 miles of blood vessels of an average-
sized adult would circle the earth four times. The body’s blood vessels can hold nearly 20 
liters of blood even though the actual total blood volume is approximately 5 liters 
(McKardle, Katch & Katch, 1996). The three major types of blood vessels consist of 
arteries, capillaries and veins, that latter of which is the focus of this review. Like 
arteries, veins contain three distinct tunics, but their walls are thinner and their lumens 
larger than those of arteries. The innermost tunic, which is in intimate contact with blood, 
is called the tunica intima. This tunic contains endothelium that lines the lumen of all 
vessels. The endothelial lining forms a slick surface that minimizes friction as blood 
moves through the vessel lumen. The tunica media is the middle, thicker layer composed 
of connective tissue with elastic fibers, which can withstand longitudinal and 
circumferential stress. This layer allows veins to tolerate changes in pressure and flow by 
providing elastic recoil and muscular contraction (Sansivero, 1998). The tunica 
adventitia, the outermost layer of the vessel wall, is composed largely of loosely woven 
collagen fibers that protect the blood vessel wall and anchor it to surrounding structures 
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(Marieb, 1992). In very large vessels, this layer may be thicker than the tunica media and 
may contain nutrient blood vessels (Sansivero, 1998).   
Veins play an important role in many physiological functions such as conduits 
that regulate the distribution of blood volume. Since 65% of the blood volume is found in 
the veins at any one time, veins are called capacitance vessels or blood reservoirs. Some 
organs have a large capacity for storing venous blood. The most significant blood 
reservoirs and their estimated capacities include: spleen (150ml), liver (200-300 ml), 
large abdominal veins (300 ml), and heart and lungs (50-100 ml and 100-200 ml). Quick 
recruitment of these stores compensates blood loses of as high as 20-25% of the total 
blood volume while maintaining adequate arterial pressure and tissue perfusion. The 
blood reservoirs not only quickly release but also rapidly accumulate blood. If central 
venous pressure increases, the liver accumulates a substantial amount of blood, doubling 
its capacity, thus functioning as a primary Hemodynamic buffer (Monos, Berczi & 
Nadasy, 1995). Blood draining from capillaries is collected by venules, small veins that 
merge to form larger veins that eventually empty into the great veins, superior and 
inferior vena cava, that converge on the heart. The capillaries feed deoxygenated blood 
into the venules or small veins. 
Since blood pressure within veins are very low (8-10 mm HG) and they can be 
thinner walled than arteries (80-100 mm HG) without danger of bursting (Archie & 
Green, 1990). However, low-pressure conditions demand special adaptations to help 
return blood to the heart. The large-diameter lumens of veins as well as valves that 
prevent back flow are another adaptation. Valves are most abundant in the veins of the 
limbs, where the upward flow of blood is opposed by gravity. Venous valves are formed 
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from folds of the tunica intima, and resemble the semilunar valves of the heart in both 
structure and function (Marieb, 1992). Most often, valves are paired and face one 
another, but occasionally there will be one or three flaps. When blood flows in a 
retrograde fashion, the valve sinuses close, preventing backflow (Sansivero, 1998). 
Venous flow is influenced by several factors. Because veins are on the low-
pressure side, they are easily compressed by the smallest of muscle contractions (muscle 
pump) or even by minor pressure changes within the chest cavity with breathing and 
contain flap-like valves that permit a one-way flow toward the heart. The alternate 
compression and relaxation of the veins, as well as the one-way action of their valves, 
provide a “milking” action, which removes wastes and propels blood back toward the 
heart. The smaller veins in the lower portion of the body empty into the inferior vena 
cava and return blood back to the right atrium. Deoxygenated blood from the upper 
portion of the body empties into the superior vena cava and joins the inferior vena cava at 
the heart level. Blood from the upper and lower portion of the body enter the right atrium 
and descends into the right ventricle, where it is then pumped through the pulmonary 
artery to the lungs. The oxygenated blood then returns to the left side of the heart through 
the pulmonary veins to begin another pass through the body (McKardle et al., 1996; 
Sansivero, 1998). 
Veins also contribute to maintenance of filling pressure of the heart. The 
prerequirement for such regulation is that the vascular bed of appropriate venous tone 
should be adequately filled with blood. During stress, such as exercise, both ventricles 
can change within a wide range; therefore an adequate amount of venous return to the 
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right heart is needed to maintain filling pressure, providing adaptation to the changing 
cardiac output (Monos et al., 1995).  
Changes in body position greatly influence the hydrostatic loads placed on the 
blood vessels. Orthostatic hypotension causes clinical problems leading to impairment of 
the brain blood supply or to orthostatic edema in tissues. Local preventative mechanisms 
such as muscle pump and venivalvular pump help to increase orthostatic tolerance 
(Monos et al., 1995).  
Venules determine the output resistance of the microcirculatory bed due to 
changes of their cross-sectional area. Other factors determining the output resistance of 
the microcirculatory vessels are the time-, flow-velocity-, and diameter-dependent 
changes in blood viscosity. The ratio between the pre- to postcapillary resistance 
determines the hydrostatic pressure of the blood in the exchange vessels and the 
filtration-resorption balance (Monos et al., 1995). 
The venular part of the microcirculation is the typical site of angiogenesis, usually 
due to enhanced metabolic requirements. It is thought that the mechanism responsible 
may be due to minor damage to the basal membrane by the endothelium-derived 
proteinases, which is followed by the growth of a capillary sprout (Monos et al., 1995). 
Evidence exists that the vein wall synthesizes bioactive substances such as NO via 
stimulation of muscarinic, thrombin and a2-adrenergic receptors, prostacyclin and 
prostaglandins. The EDRF-induced relaxation provides reciprocal control of the vascular 
tone, since blood vessels only posses vasoconstrictor fibers and have no dilatory 
innervation. A variety of vasoactive substances such as acetylcholine, angiotensin, ATP, 
bradykinin, histamine, serotonin and thrombin induce EDRF-mediated relaxation. 
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Stimuli, such as pulsatile flow, cause relaxation by increasing endothelial shear stress 
with subsequent release of EDRF. A growing body of literature suggests the existence of 
a basal secretion of EDRF, which reduces baseline venous tone (Glick, Gehman & 
Gascho, 1993).  In addition, EDRF in synergism with prostacyclin plays an important 
role in the inhibition of platelet aggregation and adhesion to the endothelial wall. 
Endothelin, which causes smooth muscle contraction, may also trigger synthesis of 
EDRF and prostacyclin through the activation of ETb receptors (Masaki, Kimura, 
Yanagisawa & Goto, 1991). Other vasoactive substances such as hyperpolarizing factor, 
histamine, and vasoconstrictor and vasodilator metabolites of arachidonic acid are also 
synthesized in endothelial cells. Endothelial cells are also important in the synthesis of 
antioxidants, conversion of angiotensin I to angiotensin II as well as the formation of 
vascular wall matrix substances (collagen, elastin, glycoproteins and proteoglycans).      
 Certain lymphoid organs, such as lymph nodes, contain specific receptors 
(homing receptors) mediated via addressins found in endothelial venules, which exhibit a 
special barrier function. These circulating effector lymphocytes leave the vasculature via 
high endothelial venules distribute circulating effector lymphocytes due to stimuli such as 
inflammation (Wu, Jalkanen, Streeter & Butcher, 1988).   
Local hemodynamic, endothelial and biochemical factors such as arachidonic acid 
–derived substances control the interaction of polymorphonuclear leukocytes (PMNLs) 
and the endothelial surface. A substantial part of PMNLs adhere to the endothelium and 
is typical for venules where linear velocity and thus the shear rate are low. Some PMNLs 
return to the circulation, while others penetrate into the interstitial space or remain 
adhered to the endothelial surface, rolling in the direction of the blood flow. The cells 
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move relatively slow and a balance is developed between PMNLs leaving the vascular 
bed and those returning to the circulation (Bienvenu & Granger, 1992). Cooperation also 
exists between the PMNLs and the endothelium surface in bactericide functions and 
inflammatory reactions (Monos et al., 1995). 
 Both arterial and venous endothelium inhibits platelet aggregation.  However, the 
thromboembolic reactions of the venules are of shorter duration compared with the 
arterioles. Platelet distribution differs between venules and platelet density is 
significantly lower, especially in the deep lower limb vessels such as the soleus and 
femoral vein endothelium (Woldhuis, Tangelder, Slaaf & Reneman, 1992). This may 
explain the pathomechanism of venous thromboembolism, help in the prevention of 
venous diseases and aid in the success of vein graft surgery.     
Veins may also aid in special regional functions. For example, the buccal part of 
the facial vein exhibits temerature-dependent myogenic tone and contributes to the 
cranial thermoregulation and emotional blushing (Mellander, Anderson, Afzelius & 
Hellerstrand, 1982). Veins may serve a venous pressure buffer function in the regulation 
of intracranial pressure due to increases in cerebral blood volume. The proximal 
segments of the caval and pulmonary veins, close to the heart, may also exhibit 
pacemaker activity and under certain pathological conditions, can serve as the site for 
ectopic beats. When an individual is in the upright position, the internal jugular vein 
serves to regulate pressure of the cerebral sinuses and intracranial pressure. Skin has a 
rich subcutaneous plexus, which contain a2-adrenoreceptors, for conservation or loss of 
heat in thermoregulation (Flavahan, 1991). The portal vein of the liver plays a dual role 
 10 
of a collector and distributor in the splanchnic circulation. In the kidney, the peritubular 
venous plexus involved in tubular absorption and secretion processes. 
2.2 Biomechanical Control  
The active and passive biomechanical control of venous tone is essential for 
functions under normal and pathophysiological conditions. The incidence of vein 
diseases is extremely high, in many countries exceeding that of arterial pathology by 
almost an order of magnitude (Ibrahim, MacPherson & Goldhaber, 1995).  
 The involvement of different biomechanical anomalies of the vein wall may 
contribute substantially to the development and maintenance of arterial hypertension.  A 
three-dimensional stress-strain relationship has been used to identify certain 
biomechanical characteristics thought to control venous tone (Fung & Liu, 1992). Due to 
the much smaller wall thickness-to radius-ratio, as well as higher distensibility in the low 
transmural pressure range, veins can greatly exceed the stress of arteries measured at 
similar pressure loads.  However, the breaking pressure for some veins is surprisingly 
high (2,873 mm HG) (Archie et al., 1990). It is thought that mechanical properties of the 
vessel wall such as collagen, elastin and its smooth muscle tone greatly affect the 
pressure-volume characteristics. At normal physiological conditions, collagen is probably 
secondary in Hemodynamic stress-bearing function of the vein wall compared with 
smooth muscle and elastin (Monos et al., 1995).  
In different physiological states, such as exercise, biomechanical properties of 
veins can change in an adaptive manner. Increases in distensibility and lumen thickness 
of veins are seen in long-term exercise due to repeated exposure to shear stress and 
cardiac output. Additionally, decreases in distensibility and elasticity are seen in the 
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elderly compared to younger individuals (Gascho, Fanelli & Zelis, 1989). The size of the 
body also affects the vein competence and is correlated with the inner diameter of the 
femoral vein (Mortensen, Talbot & Burkart, 1990). 
 The available information on the local regulation of the systemic venous tone is 
very limited with the exception of a few vessels. Many reports on the transmural pressure 
induced (stretch) venous tone response are inconclusive. However, it is emphasized that 
small increases of smooth muscle tension due to pressure may significantly reduce the 
passive dilation of the otherwise highly distensible vessels exposed to the pressure. For 
example, increases in smooth muscle tension due to increases in gravitational load could 
significantly enhance orthostatic tolerance of an individual. On the other hand, 
pathologically altered reactivity of the systemic veins may induce changes, which can 
lead to the development and maintenance of cardiovascular diseases (Monos et al., 1995).  
Intraluminal pressure-induced acute myogenic tone of smooth muscle may be 
higher in certain vessels and this myogenic response to intraluminal pressure contains a 
static and dynamic component. It is thought that elevated activity of protein kinase C in 
smooth muscle may be one cellular mechanism resulting in increased myogenic reactivity 
through the activation of stretch-sensitive nonselective cationic channels in the smooth 
muscle membrane (Davis, Donovitz & Hood, 1992).   
Evidence also suggests that apart from the intraluminal pressure, flow rate can 
also affect venous tone independently of the pressure (Bevan & Joyce, 1990). Flow-
dependent vasodilation, caused by increases in shear stress, requires intact endothelium 
for the synthesis of ATP, substance P, and Ach as well as CA2+ influx into the endothelial 
cells, changes in extracellular NA+ and its membrane gradient (Bevan & Siegel, 1991; 
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Bevan & Joyce, 1993). The flow-dependent contraction related to CA2+ influx into the 
smooth muscle cells probably differs from the calcium channel involved in the 
pressure\stretch response and is less endothelium dependent (Henrion, Klaagen & Bevan, 
1992). Special NA+ and CA2+-binding glycosaminoglycan polyanions in the extracellular 
matrix and plasma membranes of the endothelium and smooth muscle cells are thought to 
be primary flow sensors (Bevan & Joyce, 1992, 1993). 
2.3 Local Control 
2.3.1 Metabolic Control  
In systemic circulation, metabolic control is reduced or elevated, depending on 
the metabolic needs of the tissues. Tissue perfusion induces a compensatory dilation or 
contraction of resistance vessels, which in turn, elicits a regulatory decrease or increase in 
capillary blood flow. Several mechanisms for these changes have been suggested and 
include metabolites that may exert their action directly on vascular smooth muscle cells, 
or they can locally modulate norepinephrine release from sympathetic nerve endings, or 
the sensitivity of adrenergic receptors (Johnson, 1986). The contribution of venular flow 
resistance in the systemic circulation is only a fraction of the total resistance, however, 
the contractile resistance and properties of venules significantly contribute to capillary 
hydrostatic pressure and to the control of blood volume (House & Johnson, 1986). Blood 
in small veins is adjusted in accordance with the tissue fluids with respect to its Po2, Pco2, 
pH and adenosine and phosphate content. Contractility to these metabolic substances 
seems to be less sensitive in larger veins compared to small ones and may have important 
pathological implications (Honig, Gayeski, Clark & Clark, 1991). Variable amounts of 
data indicate that there are regional differences in the metabolic control of veins. Studies 
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have found that venules take part in the vasodilatory processes during and after muscle 
work. The venules of the mesenteric organs contribute mainly to the increases in blood 
volume whereas the venules in the skeletal muscle contribute only minutely to increases 
in flow. The response of venules seems to be workload dependent, responding somewhat 
slower than arterioles. Several mechanisms include an altered Po2 through oxidative 
phosphorylation, release of vasoactive substances as prostaniods or leukotrines, release of 
adenosine, ADP or ATP, or Pi, a decrease local pH as a result of increased Pco2 or lactate 
production, an increase in local K+ or local osmolarity (Marieb, 1992; Monos et al., 
1995). 
2.3.2 Oxygen 
The venous system is more capable of forming lactate from pyruvate and seem to 
be better adapted to anaerobic glycolysis that arteries (Malmqvist, Arner & Uvelius, 
1991). Veins of the systemic circulation respond to hypoxia in a different manner. For 
example, in coronary vein segments exposed to acute hypoxia induced an endothelium-
dependent contraction. Pulmonary venules responded to hypoxia with a profound 
contraction whereas placental veins showed hypoxic relaxation and reoxygenation 
contraction (Figueroa, Omar, Tejani & Wolin, 1993). The mechanism of the observed 
effects of lowered Po2 remains unclear. A reduction in the number of action potentials in 
connected with reduced periodic contractions observed during hypoxia. Also a substantial 
amount of lactic acid release has been observed in normoxic conditions whereas a 
decrease in tissue oxygen consumption can be observed with an increase in lactic acid 
production. The intracellular content of phosphocreatine is decreased, while that of ATP 
is maintained, suggesting that the rate of anaerobic glycolysis is elevated in hypoxia. 
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Other mechanisms such as decreased Ca 2+ sensitivity of the vein wall as well as a 
decrease in the release of prostaniods and leukotrines have been suspected to induce 
hypoxic contractions (Soloviev & Basilyuk, 1993).   
2.3.3 Adenosine 
Adenosine is a powerful vasorelaxant agent and in many vascular beds is thought 
to be one of the main factors mediating adjustments of resistance vessels to metabolic 
needs of the tissue. Adenosine relaxes veins in a concentration dependent manner and in 
addition to its effect on smooth muscle, it has also been reported to increase venular 
permeability (Johnson, 1986). Two receptors, in mammals, have been identified as 
powerful vasoactive agents and whose physiological function may contribute to the 
metabolic control of vessels. The presence of P1purinoceptors has been shown to mediate 
vasoconstriction by inhibiting the release of NE from adrenergic nerve terminals, whereas 
P2 purinoceptors mediated contraction in response to ATP (Mathie, Alexander, Ralevic 
& Burnstock, 1991). 
2.3.4 pH, Pco2, Lactate, Potassium and Osmolarity 
Decreased pH, elevated Pco2, and increased lactate release are thought to key 
metabolic vascular caliber adjustments in many tissues (Johnson, 1986). Lowered pH and 
elevated Pco2 have been found to decrease contractility in veins. For example, a pH shift 
from 7.6 to 6.9 inhibited the contractile response to NE, serotonin and prostaglandin in 
human hand veins (Arner & Hogestatt, 1991). In conditions were Pco2 is low, lactate may 
be released not only released from surrounding tissues but from the vein wall itself and is 
better suited for the transformation of pyruvate into lactate than arteries (Malmqvist et al., 
1991). Potassium as well as increased osmolarity is also thought to be involved in the 
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metabolic control of circulation in certain tissues. Their concentrations are released from 
the intracellular space and exert a direct effect on venous tone (Johnson, 1986).  
2.4 Ionic Control  
2.4.1 Sodium 
Transport systems regulating the distribution of sodium across cell membranes 
have been observed in the venous wall. These systems are important in adjusting 
membrane potential, intracellular calcium, intracellular pH and cell volume (Monos et al., 
1995).  
The sodium pump in vascular smooth muscle plays a very similar role as it does 
in other tissues, and is a key regulatory factor in the regulation of transmembranes NA+ 
as well as K+ concentrations and membrane potential. However, vascular smooth muscle 
cells have an extremely low number of NA+ pump sites per cell when compared with 
cardiac and skeletal muscle. Within the vascular system it appears that these pump sites 
may play a greater role in the maintenance of the resting membrane potential in venous 
rather than arterial smooth muscle cells (Allen, Kahn & Navran, 1986). A number of 
neurohumoral and vasoactive factors, including adrenergic agents, stimulate the NA+-K+ 
pump in smooth muscle. The stimulation of a-adrenergic receptors is thought to cause an 
increase in NA+ influx, due to the activation of a NA+ \H + exchanger and is dependent to 
a large extent on aerobic glycolysis (Hellstrand, Jorup & Lydrup, 1984). Venous smooth 
muscle tone and reactivity may not only be influenced by inhibition of the NA+-K+ pump 
of smooth muscle cells but also by inhibition of the NA+-K+ pump of adrenergic nerve 
endings.  
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The active NA +/CA2+ exchanger may be functionally more important in venous 
that in arterial smooth muscle. The NA +/CA2+ exchanger regulates contractility by 
moving CA2+ out of the cell, at the expense of NA + influx, which is then removed by the 
NA+-K+ pump (Monos et al., 1995).  Additionally, other mechanisms such as the NA +/H+ 
exchange system also plays an active role in maintaining intracellular pH homeostasis by 
using the electrochemical energy of the sodium gradient existing across the cell 
membrane in which cells regulate H+ extrusion and NA + influx (Escobales et al., 1990). 
Other channels such as the NA +- K+ -Cl co-transport system may govern the resting 
membrane potential and\or cell volume in vascular smooth muscle (Brock, Brungnara, 
Canessa & Gimbrone, 1986).  
The distribution of sodium within the venous smooth muscle is fairly uniform 
(Monos et al., 1995). Decreases in sodium content of vascular smooth muscle has been 
shown to both enhance and attenuate contractile responses in the presence of vasoactive 
agents or nerve stimulation, thereby playing an important role in the pathophysiology of 
hypertension. Although the direct link between sodium and hypertension is not clear, it 
appears to be specific to the cardiovascular system. Circulating factors such as 
angiotensin II may contribute to the accumulation of excess sodium in vascular tissue 
(Simon, 1978). Additionally, this accumulation in the extracellular space of arteries and 
veins may promote vasoconstriction in hypertension. In the case of veins, tissue swelling 
may reduce distensibility and is thought to facilitate the vasoconstrictor response by 




2.4.2 Potassium  
Various actions of K+ are thought to directly and indirectly play important roles in 
the alteration in membrane action potential directly or through the electrogenic NA+-K+ 
pump, alterations in cell membrane permeability and intracellular NA+, or modulation of 
NE release by sympathetic nerves. Potassium has various effects on the vascular system 
in a concentration dependent manner. For example, moderate amounts of K+ (5-10mM) 
cause dilation in vessels, whereas the response to further increases in K+ (>15mM) was 
constriction, due to the depolarization and activation of voltage-dependent calcium 
channels (Wali, Greenridge & Tugwell, 1988). Drugs such as potassium channel openers 
are used to treat hypertension and angina by causing dilation in arteries and veins through 
an increase in K+ permeability and hyperpolarization. Other potassium channels such as 
calcium-activated potassium channels are among the most commonly existing channels in 
various tissues that are activated through increases in intracellular calcium. On venous 
smooth muscle, three types exist and are referenced according to the difference in their 
conductance (large, medium and small). Additionally, various calcium-dependent 
channels identified as delayed rectifier, background and transient potassium currents and 
is responsible for the regulation of membrane potential (Beech & Bolton, 1989). 
However, these channels have been studied extensively in rabbit venous smooth muscle 
and may not be applicable to that of human venous tissue.       
2.4.3 Calcium 
Calcium plays an important role in the initiation of contraction in smooth muscle. 
Two mechanisms that activate calcium involve two CA2+ pools: the extracellular pool 
where influx and efflux are regulated by the sarcolemma and the intracellular pool, 
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regulated mainly by the sarcoplasmic reticulum (Monos et al., 1995). Calcium influx 
from the extracellular pool is mediated through stretch activated CA2+ channels, whereas 
the release of CA2+ from the intracellular pool is linked to binding of the second 
messenger to receptors in the sarcoplasmic reticulum (Kobayashi, Gong, Somilyo & 
Somilyo, 1991). Additionally, it has been shown that CA2+ is not evenly distributed 
within venous smooth muscle and may contribute to the calcium-independent part of the 
membrane potential. Intracellular concentration of ATP and other adenine nucleotides 
was also shown to influence the release of CA2+ from the intracellular store, causing a 
concentration-dependent influence on venous tone (Papageorgiou & Morgan, 1990).  
Only a few types of calcium channels have been characterized in venous smooth 
muscle. One type was activated by small depolarizations and inactivated quickly, 
whereas the other required stronger depolarizations for activation and inactivated more 
slowly. Calcium channels blockers are among the most frequently used drugs in clinical 
practice. Studies on small arteries and veins have observed that calcium channel blockers 
have more pronounced effects on the arterial than the venous side of the circulation 
(Sjoberg, Andersson, Norgren & Steen, 1987).  
Many venoactive agents utilize CA2+ in their actions and may originate from the 
extracellular or intracellular stores. For instance, a-adrenergic stimulation causes an 
increase in vascular tone through increases in CA2+ as well as myosin light-chain 
phosphorylation (Aburto, Lajoie & Morgan, 1993).  Additionally, mobilization of CA2+ 
during endothelin-induced contractions depends on extracellular CA2+ stores in arteries, 
whereas intracellular CA2+ stores are important in veins (Monos et al., 1995). Also, rises 
in CA2+ facilitate the activation of histamine and Vasopressin in venous smooth muscle.  
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In Addition to venous smooth muscle cells, venous endothelial cells also utilize 
calcium for their different functions. The biosynthesis and release of EDRF in veins is 
dependent on CA2+ entry into specific CA2+-permeable channels (Tsukahara, Gordienko 
& Goligorsky, 1993). The release of prostaglandin and thromboxane are also associated 
with CA2+ mobilization from intracellular stores (Baron et al., 1993).  
Endothelial cells are subjected to shear stresses and normal pressure by blood 
flow. These forces elicit many physiological responses in endothelial cells such as 
secretion of prostacyclin and EDRF, and an increase in CA2+. Changes in flow may 
induce either dilation or constriction depending on the level of tone in smooth muscle 
cells (Monos et al., 1995). CA2+-permeable stretch-activated channels have been 
described in arterial endothelial cells as well as venous cells. These stretch-activated 
channels cause a rapid increase and entry of CA2+ from intracellular stores that are 
associated with stretch-induced contraction (Naruse & Sokabe, 1993).  
Calcium plays an important role, not only in the initiation of contraction, but also 
in other functions that help to regulate venous smooth muscle tone. Therefore it is 
thought that alterations in CA2+ metabolism and calcium channels may play a role in the 
development and maintenance of hypertension. For instance, genetic alterations in certain 
calcium channels, appearing on the venous side, could contribute in the development of 
increased blood pressure (Hermsmeyer, 1991).       
2.4.4 Magnesium 
The majority of studies examining the effects of Mg2+ on the vascular smooth 
muscle have been done on arteries, although a few studies have conducted on veins, too 
(Chiavarelli et al., 1992). Magnesium is a significant natural CA2+ antagonist, inhibiting 
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the voltage-dependent and receptor-dependent channels. Reductions in Mg2+ 
concentration enhance CA2+ influx into the vascular smooth muscle cells leading to a 
consequent increase in venous tension and reactivity (Altura & Altura, 1984). For 
example, decreased Mg2+ concentrations of human arteries as well as veins caused an 
increase in basal tension and potentates the contractile response of the vessels to certain 
hormones. Conversely, high concentrations of Mg2+ resulted in vasodilation of veins 
(Chiavarelli et al., 1992). Total withdrawal of Mg2+ had a reciprocal effect on the smooth 
muscle tone, starting with an endothelium-dependent and calcium-dependent dilation 
followed by a sustained endothelium-independent contraction. Mg2+ is therefore an 
important contributor in regulating venous tone and protecting the endothelium against 
spasm induced by a reduced Mg2+ concentration in the pathophysiological range (Szabo 
et al., 1992).  
2.4.5 Chloride 
In the past, scientists have neglected the importance of chloride in vascular 
smooth muscle. Recent research has estimated that chloride concentrations in vascular 
smooth muscle is much higher than those found in skeletal and cardiac muscles and is 
thought to be important in many steps of the excitation-contraction coupling in muscle 
(Bretag, 1987). Chloride is transported across the cell membrane by several different 
mechanisms, which include cotransporters, exchangers, and conductive channels. These 
mechanisms are thought to be involved in actions such as cell volume regulation, and 
anion exchanges for the regulation of intracellular pH (Zhang, Carella, Altura  & Altura, 
1991). Several types of chloride channels have been identified, in mammals, according to 
their conductance and are activated by the release of CA2+ from intracellular stores and 
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through voltage-dependent calcium channels. The action of Cl¯ is suggested to contribute 
significantly in the regulation of arterial and venous tone and contractility (Queroy & 
Verdetti, 1992).  
2.5 Hormonal Control (Constrictor Agents) 
2.5.1 Angiotensin II 
Angiotensin-converting enzyme (ACE) or kininase II, angiotensin and 
angiotensin receptors have been shown to exist in vascular tissue. In fact angiotensin I 
has been shown to convert to angiotensin II (ANG) in the human hand vein (Mizuno et 
al., 1991). However there is an inconsistency in the literature to support single and\or 
multiple angiotensin receptors in vascular smooth muscle (Li et al., 1996). The dominant 
venoactive effect of ANG II in human veins is constriction due to sympathetic nerve 
stimulation via an increased release of NE from the nerve terminals in smooth muscle 
(Webb, Benjamin, Cockcroft & Collier, 1989). Certain pathophysiological conditions 
alter the effect of ANG II on the venous system. For example, contractile responses to 
ANG II are increased in the forearm veins of hypertensive patients compared to healthy 
counterparts (Sudhir et al., 1990).  Responses to ANG II in hypertension may increase the 
permeability of venules and veins to plasma components, which may be an additional 
pathogenic factor.  
2.5.2 Neuropeptide Y 
Neuropeptide Y (NPY) is a potent contractile agent found in human vessels such 
as mesenteric, saphenous and uterine veins (Fried & Samuelson, 1991; Luu et al., 1992). 
NYP is thought to exert both post-junctional (vasoconstrictor effects) and pre-junctional 
(inhibition of NE release) effects. Neuropeptide Y not only responds to nerve stimulation 
 22 
but also to a variety of vasoconstrictor agents and is coreleased with NE in an abundance 
of sympathetic fibers. NYP plays a functional role in neurotransmission, due to 
presynaptic site of action, by inhibiting transmural nerve stimulation evoked by NE 
efflux (Daly, Roberts, Ruffolo & Hieble, 1988). 
In addition to the direct vascular effects, NYP also upregulates the adhesiveness 
of certain veins to leukocytes and may serve as modulators of not only the neuromuscular 
unit but also the interaction of endothelial cells with leukocytes (Sung, Arleth & 
Feuerstein, 1991).  
2.5.3 Neurotensin 
The portal vein of certain mammals is the only vessel on which Neurotensin 
effects were studied. Neurotensin increased basal tension, frequency and peak phasic 
contraction (Monos et al., 1995).  
2.5.4 Vasopressin 
Vasopressin (AVP) is a vasoconstrictor peptide that has an effect on a variety of 
veins. AVP was shown to induce contraction in the human chorionic plate where as the 
mesoappendix vein did not respond. The action of AVP is thought to be the result of in an 
increase of CA2+ in smooth muscle cells from intracellular stores. Although AVP has 
exerts direct venoconstrictor effects, actual circulating levels of AVP seem to be 
important in the regulation of vascular capacitance through changes in autonomic 
nervous function (Martin & McNeil, 1991). The effect of AVP is important in the 
treatment of hemorrhage in cirrhotic patients in which blood velocity and blood flow are 
decreased primarily due to arteriolar constriction. Additionally, actions of AVP may be 
enhanced in certain pathological conditions such as left ventricular dysfunction and heart 
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failure in which the inhibition of AVP causes venodilation and a reduction in mean 
circulatory filling pressure (Raya, Gay & Goldman, 1990).   
2.6 Relaxing Agents 
2.6.1 Atrial Naturetic Peptide 
Atrial Naturetic peptide (ANP) is a far more effective dilator in arteries and 
arterioles than veins. The relaxing effect produced by ANP may depend on the 
contribution of alpha-1, alpha-2 and intrinsic vasoconstrictor components to the level of 
smooth muscle tone (Faber, Gettes & Gianturco, 1988).  The majority of studies use 
animal subjects with only few studies showing no effect of ANP on human peripheral 
venous tone. However, ANP is shown to increase venous distensibility in human forearm 
veins probably through inhibition of angiotensin- or thrombin-induced secretion of 
endothelin (Ando et al., 1992).    
2.6.2 Calcitonin Gene-Related Peptide 
Calcitonin gene-related peptide (CGRP) is a sensory Neuropeptide that has the 
ability to produce long-lasting dilation in diverse parts of the vasculature such as human 
mesenteric and saphenous veins (Luu et al., 1992). The dilatory effects of CGRP may be 
exerted through the release of endothelial vasorelaxant substances such as prostacyclin 
and adenylate.  Subsequently, these endothelium-dependent responses to CGRP may vary 
from vein to vein.  
 CGRP also functions as a peptide that stimulates vascular proliferation that is 
associated with cAMP formation. Therefore, CGRP may be important in the formation of 
new vessels during physiological stress and pathophysiological stress such as ischemia 
(Haegerstrand et al., 1990).  
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2.6.3 Vasoactive Intestinal Polypeptide 
Vasoactive intestinal polypeptide (VIP) induces responses in veins containing 
VIP neurons in the nonadrenergic noncholinergic vasodilation (Hardebo, Kahrstrom, 
Owman & Salford, 1987). However, some veins such as the saphenous veins are less 
sensitive than internal mammary veins possibly because of the lower receptor density and 
are thought to be secondary to hypertension (Luu et al., 1993).  
2.7 Agents with Constrictor and Relaxant Effects 
2.7.1 Bradykinin 
Bradykinin (BK) and related kinins are potent vasodilators found in the majority 
of peripheral vascular beds, however they do contract some arteries and most veins. This 
is due to two types of BK receptors, which exhibit various responses in arterial and 
venous smooth muscle. B1 receptors mediate contraction of arterial smooth muscle while 
B2 receptors are involved in the relaxation of arteries and increase vascular permeability. 
Both B1 and B2 receptors contract venous smooth muscle due to intracellular and 
extracellular CA2+ mobilization (Takata et al., 1990). Additionally, mechanisms, which 
may explain BK-induced vasodilation veins, may involve mediators such as EDRF and 
prostacyclin (Dachman, Ford, Blaschke & Hoffman, 1993). 
2.7.2 Eicosanoids 
Venous tissues, along with other tissues, produce and release various types of 
prostaniods. Prostanoids such as prostacyclin and thromboxane make up a large 
percentage of metabolites found in veins (Monos et al., 1995). The action of prostanoids 
has different effects on the vasculature with contracting effect in some vascular beds and 
relaxation in others. Prostacyclin is shown to cause relaxation in human hand veins 
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whereas thromboxane exhibited a contractile response in the saphenous vein, which may 
be due to thromboxane-specific receptors that mediate a rise in calcium (Kent et al., 
1993).  
Different humoral agents can modify vasoactive prostanoid production of the 
vessel wall. For example, norepinephrine increases the release of both prostacyclin and 
thromboxane, whereas Vasopressin increased only thromboxane and BK increased only 
prostacyclin release.  Additionally, plasma itself stimulates prostacyclin production of 
certain veins (Brunkwall et al., 1989).  
Mechanical factors have also been shown to affect vasoactive prostanoid in the 
control of venous smooth muscle tone and thrombus formation. For instance, an increase 
in the rate of perfusion can boost the release of thromboxane whereas a reduction in 
blood flow can impair the ability of the venous wall to produce prostanoids (Onohara et 
al., 1993). In contrast, exercise training does not seem to affect the ability of the venous 
wall to release prostanoids (Brunkwall et al., 1989).  
Vasoactive prostanoid production by the venous wall is altered by certain 
pathophysiological conditions. For example the ability of venous grafts to produce 
prostacyclin has been shown to be impaired and this seems to be connected with poor 
outcomes such as neointimal hyperplasia and thrombogenicity (Onohara et al., 1993). 
Additionally, an altered balance of prostacyclin and thromboxane production is linked to 
venous wall disease and is used as markers for venous occlusion thrombosis (Eldor et al., 




2.7.3 Endothelial Relaxing Factor       
A variety of endothelial-derived relaxing and contracting factors such as nitric 
oxide (NO), prostacyclin, endothelium-derived hyperpolarizing factor, endothelin and 
thromboxane play a role in the endothelial-dependent control of vascular tone (Rongen, 
Smits & Thien, 1992). The chemical structure of endothelium-derived relaxing factor, 
nitric oxide, activates cytoplasmic guanylate cyclase and thereby stimulates intracellular 
guanylate 3’, 5’-cyclic monophosphate (cGMP) accumulation in vascular smooth muscle 
cells and platelets. cGMP functions as a second messenger to cause vascular muscle 
relaxation, inhibition of platelet aggregation and adhesion to vascular endothelial surfaces 
(Monocada, Palmer & Higgs, 1991). Arterial and venous EDRF are closely similar 
although the pathway of action is different in arteries compared to veins (Buga et al., 
1989; Yang et al., 1991). Endothelial-derived factors are determinants of the resting 
venous tone, which are dependent on an intact endothelium for a large number of 
vasodilator and vasoconstrictor substances. Additionally, the endothelial responses vary 
within the venous system and responses are generally smaller for veins compared to 
arteries, due in part, to the ability of the arteries to form more endothelium-derived 
relaxing factor (Barker, Anderson, Treasure & Piper, 1994). In fact, the relaxation of 
veins to vasoactive agents such as acetylcholine, has an endothelium-dependent relaxant 
effect in human artery, but causes contraction on the veins. The differences in 
responsiveness of veins to vasoactive agents via EDRF may be due to 1) a more 
pronounced and direct smooth muscle effect of acetylcholine in veins; 2) the decreased 
ability of venous endothelial cells to release of EDRF; and 3) the depressed 
responsiveness of venous smooth muscle to the relaxing factor (Rubanyi & Vanhoutte, 
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1988). Furthermore, flow velocity and O2 tension may be another possible explanation 
since these factors are lower in the veins.   
2.8 Endothelial Constrictor Factors 
A number of constrictor factors are produced by the endothelium such as 
endothelin. Endothelin (ET-1) is a very potent vasoconstrictor peptide found throughout 
the vasculature. In fact, veins are more sensitive to this peptide than arteries compared to 
EDRF (Yanagisawa et al., 1988). Mechanisms of action of ET-1 suggest the mobilization 
of CA2+ from internal stores as well as ATP-sensitive potassium channels. Regulation of 
vascular tone is mediated by EDRF released from platelets and\or neutrophil 
granulocytes causing a basal vasodilator tone in veins. Also, NO derived from the central 
nervous system and from hepatic Kupffer cells, may also reach veins and thus influence 
their tone and responses. Diffusion between arterioles and accompanying venules is 
another possibility by which local vascular tone can be influenced (Falcone & Bohlen, 
1990).  
In addition to ET-1, other agents elicit endothelium-dependent constriction. It has 
been shown that venous endothelial cells can metabolize arachidonic acid into a 
vasoconstrictor prostanoid. Also, the endothelial cells may control smooth muscle tone 
by indirect mechanisms such as the rubbing off of endothelial cells, which inhibited the 
release of NE by EDRF (Greenberg, Diecke, Peevy & Tanaka, 1990). Although little is 
known about the role of EDRF in venous pathology, elevated levels of plasma ET have 
been implicated in several pathological conditions such as hypertension, myocardial 
infarction and cardiogenic shock (Leppaluoto & Ruskoaho, 1992; Bax, Bos & Saxena, 
1993; Barber, Wang, Glovickzi & Miller, 1997). 
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2.9 Histamine 
Two types of histamine receptors are found in venous tree, which include 
excitatory receptors (H1) and inhibitory receptors (H2). Both receptors have been 
associated with two distinct intracellular second messenger systems. The H1 receptors 
mediate many of their effects via inositol phospholipid hydrolysis; H1 also increases the 
release of calcium (Hill, 1991). The H2 receptors are coupled via a G regulatory protein 
to adenylate cyclase and stimulate cAMP formation; H2 receptors results in calcium 
depression. The sensitivity to histamine varies from one vein to another and it is thought 
that H1 receptors, which liberate EDRF, predominate over H2 receptors. Therefore, 
maximum tension development in some veins is substantially higher than others (Tsuru, 
Kohno, Iwata & Shigel, 1987).    
2.10     Neurokinins 
Three different Neurokinins and three neurokinin receptors have been observed: 
substance P (SP), neurokinin A (NKA) and neurokinin B (NKB), which are most 
effective on the NK-1, NK-2 and NK-3 receptors. NK-1 is suggested to mediate 
peripheral vasodilation and exocrine secretion, NK-2 to stimulate bronchial muscles and 
to facilitate the release of catecholamines and NK-3 to promote the release of 
acetylcholine in peripheral organs (Regoli et al., 1989). The cGMP pathway through NO 
production in venous endothelial cells activates the mechanisms of action of neurokinins, 
such as substance P. All human veins studied responded with relaxation to neurokinins, 





Opiates, such as morphine, have a dilator effect on the venous system (Hakim, 
Grunstein, & Michael, 1992). Mechanism of vasodilatory action exhibited in morphine 
may be attributable to sympathetic inhibition mediated by the presynaptic opiate 
receptors of the veins themselves or may also be mediated via the opiate receptors in the 
brain stem (Kobari, Gototh & Fukuuchi, 1985). 
2.12     Serotonin 
The effect of serotonin (5-HT) on the cardiovascular system is complex, including 
bradycardia and tachycardia, hypotension and hypertension, and vasoconstriction and 
vasodilation. These actions are mediated by three main sets of receptors called 5-HT1, 5-
HT2 and 5-HT3 receptors. In most cases the majority of responses to veins to 5-HT 
receptors agonists is contraction, which is highly dependent on the presence of 
extracellular calcium (Bodelsson, Tornebrandt, Bertilsson & Arneklo-Nobin, 1992). 
Serotonin has also been observed to induce vasodilation in certain veins. Three 
mechanisms of action that may attribute to the vasodilatory effects of 5-HT include 
inhibition of NE release from sympathetic nerve endings, direct vascular smooth muscle 
relaxation and release of EDRF (Gothert, Molderings, Fink & Schlicker, 1991). Serotonin 
is also suggested to play a role in the pathogenesis of certain types of hypertension.  
2.13     Somatostatin 
Somatostatin has both constrictor and dilatory effects on venous smooth muscle 
that is not endothelium-dependent. Somatostatin may act on specific receptors, but the 
mechanism of venoconstriction by somatostatin and the interaction with vasoactive 
agents is still unclear. However, the most important role of somatostatins seems to be in 
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the treatment of portal hypertension. Somatostatins are shown to increase portal venous 
outflow, reduce portal pressure and increase portal venous resistance (Rice, 1989).      
2.14     Neural Control of Veins 
The sympathetic nervous system controls the motor innervation of veins and is 
responsible for the contraction and relaxation of muscle layers in the tunica media that 
change vessel diameter. Afferent fibers also supply veins and are responsible for pain 
sensation. In great vessels near the heart, the afferent fibers react to changes in blood 
pressure and stimulate the autonomic system to respond these changes (Sansivero, 1998).  
2.15      Influence of Temperature on Venous Tone 
Alpha2-adrenoceptors, found in cutaneous arteries and veins, are responsible for 
the unique thermosensitivity, enabling constriction during local cooling to prevent heat 
loss (Flavahan, 1991). Superficial veins are temerature-dependent and are important in 
the regulation of environmental and skin temperature. However, these factors influence 
not only venous compliance, but also the responsiveness of the veins to the effects of 
constrictor agents. An increased responsiveness to constrictor agents such as 5-HT at low 
temperatures (23o C) were observed in several studies (Aellig, 1994; Flavahan, 1991). 
Additionally, an application of ice to the forehead has shown to affect cutaneous 
circulation by causing venoconstriction of the forearms (Sumner, Zelis, Bennet & 
Gascho, 1989).  
2.16     Effects of Age on Venous Tone 
Although declines in vasodilation and constriction have been observed in older 
individuals, the mechanisms for this decline are controversial. For example, evidence 
suggests that the decline in vasodilatory action is associated with a specific decrease in B-
 31 
adrenoreceptor-mediated vascular relaxation (Pan, Hoffman, Pershe & Blaschke, 1986). 
Other data suggests that the decreases in Beta-adrenoreceptor mediated smooth muscle 
relaxation with age was not due to a decrease in the number of Beta-adrenoreceptors, but 
to a decrease in cAMP accumulation induced by Beta-adrenoreceptor stimulation and 
probably another defect distal in the adenylcyclase pathway (Tsujimoto, Lee & Hoffman, 
1986). This blunted response was also seen in hypertensive patients. Studies where also 
carried out on the venoconstrictor responsiveness with age. Data have shown that a 
decrease in constrictor action is observed with age, although the mechanism responsible 
for this decline is not clear. Additionally, several studies have shown no differences in 
responsiveness to constrictor agents in old and young subjects (Pan et al., 1986). 
However, suggestions for the decline in venoconstriction in older individuals are 
associated with an age-related blunted response in post-synaptic a2-receptors or a down 
regulation of receptors due to a decrease in sympathetic tone (Supiano et al., 1991).        
2.17 Effects of Disease on Venous Function 
The role of the venous system in cardiovascular disease has been mentioned briefly 
throughout the paper. It appears that arteries as well as veins play an important role in 
many cardiovascular-related conditions. For example, hypertensive subjects exhibit a 
reduction in forearm venous distensibility compared to healthy counterparts. Possible 
mechanisms contributing to the decreases in distensibility include increases in venomotor 
tone as well as a reduction in forearm vasodilatory capacity (Walsh, Hyman & Maronde, 
1969). Additionally, Sudhir et al., 1990, found that veins from hypertensive patients 
exhibited an increased sensitivity to angiotensin II as well as reduced a-adrenoceptor 
responsiveness, linking the venous system to certain cardiovascular diseases.   
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The venous function has also been related to other cardiovascular-related diseases 
such as CHF, in which venous tone is shown to a direct relation with the severity of the 
disease (Ikenouchi et al., 1990; Sato et al., 1989). A reduction in venous compliance has 
also been observed in hand veins of patients immediately following a myocardial 
infarction. In varicose veins, functional, biochemical, and structural changes are seen, in 
which endothelin-1 is elevated but the contractile response is diminished (Thulesius, 
Ugaily-Thulesius, Gjores & Neglen, 1988; Blochl-Daum et al., 1991; Lowell, Glovickzi 
& Miller, 1992). In fact, certain endothelin receptors have been characterized in varicose 
veins. Additionally, the diminished contractile response may be due to the 
downregulation of these receptors (Bax et al., 1993; Barber et al., 1997).   
Certain peripheral vascular diseases such as PVD may be affected by venous 
function. Although underinvestigated, the venous system may play a more profound part 
than expected in conditions such as deep vein thrombosis (DVT) and symptoms 
associated with PVD. Schina et al., 1993, has shown that the incidence of DVT was 
closely linked with venous physiologic parameters: more specifically venous filling and 
ejection fraction. Moreover, the incidence of DVT increased significantly with age-
related changes in these parameters.  









  3.1 Subjects 
Twenty-four males and females were recruited to participate in this study. 
Individuals with any acute medical condition and\or active infection, on drugs that affect 
vascular function, and\or tobacco users were excluded. All subjects were given informed 
consent and the Ethics Committee of Louisiana State University was approved the study. 
Prior to testing, all subjects were asked to avoid drugs that affect cardiovascular function 
and\or use tobacco. Subjects reported to the laboratory in the Kinesiology department at 
similar times for each testing session. A dietary recall was given to participants along 
with instructions regarding the testing procedures. 
3.2  Limitations  
This study was limited to apparently healthy subjects 18-81 years of age from 
South Louisiana who were without any acute disease and who were not taking vasoactive 
drugs. Additionally, all subjects were students from the Department of Kinesiology or 
participants in the Exercise Training and Functional Ability in Older Adults Study 
conducted at Louisiana State University during 1998-2000.  
3.3 Experimental Measurements 
Each experimental session involved the measurement of forearm blood flow 
(FBF) at rest and following 5 minutes of forearm occlusion using an EC-5R 
plethysmography system, which consisted of arterial inflow (AI), venous capacitance 
(VC) and venous outflow (VO) for each session. 
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Upon arrival to the laboratory, the subject’s height, weight, hip to waist ratio, 
body composition, forearm circumference and length as well as grip strength were 
obtained. Thereafter, each subject was placed in a supine position for 20 minutes 
preceding the evaluation of FBF.  
 Prior to each measurement session, blood pressure cuffs were positioned 
around the midpoint of the participant’s upper arm and wrist. Additionally, a mercury-in-
silastic strain gauge, 2-3 cm less than the forearm circumference, was placed around the 
forearm approximately 10 cm distal to the olecranon process (Cramer et al., 1983; 
Sinoway, Musch, Minotti & Zelis, 1986). The forearm was extended and slightly 
supinated and supported by a Styrofoam block to be elevated above the heart level.  
 In order to obtain blood flow at rest, hand circulation was occluded for 1 
minute by inflating the wrist cuff to 240 mmHg. Following 1 minute of wrist occlusion, 
the chart recorder was started at 5 mm\sec and the calibration marker was activated 
followed by inflating the upper arm cuff to 50 mmHg for 2 minutes and AI measurements 
were taken. This pressure was sufficient to occlude deep and superficial veins in the 
forearm to allow for venous filling (Cramer et al., 1983). After 2 minutes of venous 
occlusion the chart recorder was increased to 30 mm\sec followed by deflating the upper 
arm cuff and measurements were obtained. This procedure was repeated once and 
separated by 5 minutes.    
 Total limb blood flow following ischemia was obtained by inflating the upper 
arm cuff to 240 mmHg for 5 minutes (Sinoway et al., 1986). After 4 minutes of upper 
arm occlusion, the wrist cuff was inflated to 240 mmHg for 1 minute, followed by 
deflating the upper arm cuff to 50 mmHg in order to acquire AI measurements. The upper 
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arm cuff pressure remained for 2 minutes and measurements following ischemia were 
obtained as described above.  
Throughout the testing procedures, heart rate and blood pressure were obtained at 
the following time points: rest, during and immediately after occlusion. For the duration 
of the testing procedures, which lasted approximately 25 minutes, the subject remained in 
a supine position with minimal movement. Forearm venous outflow measurements were 
performed once, exactly one week apart. 
3.4  Data Analysis  
1. Arterial inflow rates were calculated by measuring the initial slope. This was 
determined by drawing a line on the recorded output tangent to the first few 
pulses following cuff inflation. Flow rate was expressed as a volume change per 
unit time such as ml’s of blood flow/ 100 ml’s of tissue/ minute. 
2. Venous capacitance was calculated by measuring the distance in mm from the 
baseline to the maximum height of the inflow curve and dividing this distance by 
the height of the calibration mark (CAL). 
3. Forearm venous outflow was calculated for each session by measuring the 
distance in mm from the baseline to the maximum height of the (CAL).   
Subsequently, VO was calculated at 0.5 (VO.5) and 2 (VO2) seconds after cuff  
deflation, and the respective excursions of the curve from the baseline at both 
time periods were measured and divided by CAL. The resultant number, a 
volume, was converted into a rate of flow in ml per min per 100 ml of tissue by 
introducing a time normalizing factor using the following formulas (Cramer et al., 
1983): 
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  VO.5 = excursion from the baseline\CAL * 120 
  VO2 = excursion from the baseline\CAL * 30  
The outflow interval between 0.5 and 2 seconds (VO.5-2) was calculated by the 
equation: 
  VO.5-2 = (4\3) VO2 – (1\3) VO.5   
     4.  The area under the curve (AUC) was also selected as a potentially more 
meaningful measure of blood flow. The area under the curves for VO between the 
0.5 sec and 2.0 sec time intervals in a subset of the study sample were examined 
for an association with the accepted method of estimation by slope calculation.  
     3.5  Statistical Analysis  
Statistical analysis was performed using the SPSS for Windows statistical 
package (version 10.0). Descriptive data was presented, as mean ± sd. Intraclass 
correlation coefficients were derived from repeated measures Analysis of Variance for 
the purpose of examining the test re-test reliability of FBF, blood pressure, and heart rate 
during rest and following ischemia in visits I and II. Alpha was set a-prior at 0.05. A 
Pearson Product Moment Correlation was used to compare FBF with anthropometrical 
















Table 1 shows the characteristics of male and female subjects.  Twenty-four 
apparently healthy subjects (N=14 females, N=10 males) were recruited to participate in 
this study.  All of the original 24 subjects completed the study.  Subjects were required to 
successfully complete both trials to be included in the final results.  Participants ranged in 
age from 18 – 81 yrs.  There was a wide-inter-individual height and weight range among 
all subjects tested with a maximum height recorded as 75 inches and minimum height 
was recorded as 61 inches.  Weight ranged from a maximum of 113.6 kg to a minimum 
weight of 50.4 kg.  Body Mass Index (BMI) ranged from a maximum value of 35.85 to a 
minimum value of 19.34.  Body fat percentage ranged from a maximum value of 44% to 
a minimum value of 12%. Arm length and circumference extended from maximum 
values of 29 and 31.5 cm to minimum values of 22 and 21 cm, respectively. The average 
of three maximal voluntary contractions were taken with a handgrip dynamometer and 
ranged with maximum value of 66.3 kg to a minimum value of 20.6 kg. Blood pressure 
and heart rate were recorded at rest and ranged from highest to lowest value of 170 to 94 
mmHg systolic, 97 to 35 mmHg diastolic and 85 to 45 beats per minute for heart rate.   
4.2 Within-Day Flow at Rest 
FBF for within-day measures at rest are reported in table 2. Values for all FBF 
indices were in expected ranges as reported by others. Intraclass Correlation Coefficient 
(ICC) for FBF are also reported in table 2, which show strong reliability for all blood 
flow indices, with the AI having the lowest ICC.  
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Table 1. Subject Demographics 
 Minimum Maximum Mean ± SD 
Age 19 81 39.9 ± 18 
Height (in) 60 75 66.9 ± 3.84 
Weight (kg) 49.5 113.6 72.6 ± 16.5 
BMI 19.3 35.8 24.5 ± 3.89 
Body Fat 12 44 24.1 ± 6.62 
Arm Lg (mm) 22 29 24.8 ± 1.91 
Arm Circ (mm) 21 31.5 26.1 ± 3.35 
MVC 20.6 66.3 38.2 ± 12.1 
SBP 94 170 119.7 ± 20.3 
DBP 35 97 60.2 ± 16.7 
HR 45 85 63 ± 11.1 
Arm Lg = arm length, Arm Circ = arm circumference, BMI = body 
mass index, MVC = maximal voluntary contraction, SBP = systolic 
blood pressure, DBP= diastolic blood pressure, HR= heart rate. 
 
Table 2. Within-Day 1 Resting Blood Flow Indices 
Indices Minimum Maximum Mean ± SD ICC 
AIA 1.86 7.95 4.45 ± 1.63 
AI B 1.92 7.93 4.28 ± 1.71 
.87 
VCA 1.50 3.60 2.78 ± 0.46 
VC B 1.40 3.40 2.73 ± 0.46 
.93 
VO.5 secA 55.2 140.4 99.5 ± 26.4 
VO.5secB 48.0 140.4 94.4 ± 27.3 
.94 
VO2secA  24.0 67.8 48.2 ± 12.2 
VO2secB 22.0 64.5 46.1 ± 11.6 
.96 
VO.5-2A 13.6 48.0 31.1 ± 9.51 
VO.5-2B 12.6 49.6 29.9 ± 8.48 
.97 
AI = Arterial inflow, VC = Venous capacitance, VO .5 sec  = Venous outflow at .5 seconds, VO 2 sec = Venous 
outflow at 2 seconds, VO.5-2 = venous outflow between the time intervals at .5-2 seconds.  
 
4.3 Between-Day Flow at Rest 
FBF for between-day measures at rest are reported in table 3. All blood flow 
values were similar to those reported for within-day measures in table 2. However ICC’s 
for FBF between-days showed weaker reliability, with the least reliable measure reported 








Table 3. Between-Day Resting Blood Flow Indices  
Indices Minimum Maximum Mean ± SD ICC 
AI I 2.00 8.00 4.01 ± 1.50 
AI II 2.00 7.75 3.69 ± 1.36 
.51 
VC I 2.00 4.00 2.93 ± 0.47 
VC II 1.90 4.00 2.82 ± 0.57 
.62 
VO.5 secI 36.0 146.4 96.8 ± 27.6 
VO.5secII 48.0 140.4 94.4 ± 27.3 
.70 
VO2secI  39.6 134.0 91.2 ± 26.4 
VO2secII 25.2 69.0 45.3 ± 12.1 
.51 
VO.5-2I 16.4 42.4 30.1 ± 7.75 
VO.5-2II 18.0 54.8 30.1 ± 9.23 
.43 
Other acronyms are reported in Table 2. 
4.4 Between-Day Flow Following Occlusion 
Between-day measures for FBF following occlusion are reported in table 4. All 
blood flow values reported in table 4 were in expected range. Similarly, ICC’s reported 
for AI were as anticipated with reliability being somewhat higher than those reported for 
between-day measures at rest. 
Table 4. Between-Day Ischemic Blood Flow Indices  
Indices Minimum Maximum Mean ± SD ICC 
AI I 20.0 35.8 26.6 ± 4.47 
AI II 20.0 45.9 26.3 ± 6.11 
.81 
VCI 1.60 3.40 2.56 ± 0.45 
VCII 1.80 3.50 2.73 ± 0.43 
.56 
VO.5 secI 60.0 146.4 98.6 ± 26.7 
VO.5secII 39.6 132.0 97.1 ± 25.6 
.70 
VO2secI  26.7 72.6 49.3 ± 12.8 
VO2secII 27.0 70.2 49.4 ± 11.4 
.64 
VO.5-2I 12.0 50.8 32.8 ± 10.1 
VO.5-2II 18.0 51.6 33.4 ± 8.45 
.63 
Other acronyms are reported in Table 2. 
 
4.5 Correlation Among Variables 
An analysis of co-variance was performed to determine the correlation between 
FBF for Day I and II under both conditions with anthropometrical measures, age, gender, 
and HR among the 24 subjects tested. AI was the only measure to correlate strongly with 
VC for both days with day II showing a weaker association (r = .500, p< .09; r = .329, p< 
.11). However, AI showed a somewhat lesser correlation when compared to VO2 and 
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VO.5-2 for day II (r = .394, p< .05; r = .399, p< .05), respectively. In addition, venous 
measures were strongly correlated with various venous indicators. For example, VC 
demonstrated a strong association for the following venous markers for day I: VO.5, VO2 
and VO.5-2 (r = .538, p< .005; r = .753, p< .0001; r = .789, p< .0001), respectively. As 
expected, VO.5 was associated with VO2 and VO.5-2 for day I (r = .877, p< .0001; r = .431, 
p< .03) as well as VO.5-2 for Day II (r = .574, p< .002). VO2 was also strongly correlated 
with VO.5-2 for day I (r = .896, P< .0001). Additionally, VC was correlated with the 
following venous markers: VO.5, VO2 and VO.5-2 (r =  .509, p< .01; r = .651, p< .0004; r 
= .702, p< .0001) for day II, respectively. Venous marker VO.5 was also associated with 
VO2 (r= .931, p< .0001) as well as VO.5-2 (r = .682, p< .0001) for day II. Lastly, a 
significant association was found betweenVO2 and VO.5-2 for day II (r = .902, p< .0001). 
Various venous markers demonstrated a relationship with heart rate. Heart rate was 
inversely associated with all venous indices for day II only (r = -.417, p< .04; r = -.501, 
p< .01; r = -.485, p< .01; r = -.378, p< .0001). 
 Certain anthropometrical measures were also found to be inversely associated 
with FBF. Height was associated with VC at both days  (r = .352, p< .09; r = .227, p< 
.19). An inverse association was also seen for between height and VO.5 and VO2 for day 
II only (r = -.273, p< .19; r = -.377, p< .06). AI was the only measure found to have an 
inverse association with body fat (r = -.359, p< .08).  Markers VO.5 and VO2 
demonstrated an inverse relationship with arm length for day II only (r = -.430, p< .03; r 
= -.344, p< .09), respectively. AI demonstrated an inverse association with gender for day 
I only (r = -.345, p< .09).  Similarly, VC demonstrated a strong, inverse relationship with 
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gender for day II only (r = -.513, p< .009). Finally, venous marker VO.5-2 was inversely 
associated with age for day I only (r = -.340, p< .10).        
4.6 Multiple Regression 
A stepwise regression was performed between venous measures and subject 
characteristics. Arm length, hence vessel length, was found to have important predictive 
value in VO markers measured at the time interval of .5 seconds (F = 4.979, p< .03). 
Similarly, gender was found to have important predictive value for VC (F=7.862, p< .01). 
4.7 Area Under the Curve        
Quantification of forearm blood flow using venous plethysmography essentially is 
based on a derived slope of the change in diameter of the forearm. While this technique 
has gained wide acceptance, there is some error that is associated with this technique 
largely due to problems associated with selecting the points across which the slope is 
determined. Therefore, there has been some interest in selecting the area under the curve 
of the change in diameter during a standardized time period as a potentially more 
meaningful measure of blood flow.  Therefore, we examined the area under the curves for 
venous outflow between the 0.5 sec and 2.0 sec time intervals in a subset of the study 
sample and examined these areas for an association with the accepted method of 
estimation by slope calculation. Thus, we were simply assessing the construct validity of 
the measure.   
The method used by Cramer et al., 1983, to assess blood flow was compared with 
AUC technique. Figure 4.1 & 4.2 revealed a strong correlation between both methods for 
resting VO at the time interval .5-2 sec for day I (r = .86, p< .01 for VOA; r = .85, p< .01 





























    
Figure 4.2 Cramer’s Method VS AUC DAY I B  
 
Figure 4.3 shows a comparison of both measurement techniques for VO following 
ischemia at the time .5-2 sec. Similarly Cramer’s method was strongly correlated with 
AUC, showing a correlation coefficient of r = .90 (p< .01). Additionally, the short-term 
reliability of the AUC technique was assessed during rest, revealing an ICC of r = .90 (p< 
.71).     
 
 






























 The purpose of this study was to evaluate the reproducibility, using venous 
occlusion plethysmography, of forearm venous outflow during rest and following 
ischemia. A secondary purpose was to compare the association of FBF with subject 
characteristics such as anthropometrical measures, age, gender, and HR among the 24 
subjects tested. A stepwise regression was also performed to determine predictive value 
between venous measures and subject characteristics. Finally, the construct validity of 
area under the curve was compared to the accepted method used by Cramer to determine 
venous outflow.    
All data for the variables of interest were in expected ranges.  Arterial inflow 
measures at rest ranged from 1-8 ml/100ml of tissue/minute. These measures were 
similar to that reported by Altenkirch et al., 1989, 1990. Measures obtained for AI 
following ischemia coincided with those found by Sinoway et al., 1986, extending from 
20-46 ml/100 ml of tissue/minute. Additionally, all venous measures during both 
conditions were comparable to those established by Cramer et al., 1983, with VC ranging 
from 1-4 and VO.5-2 ranging from 12-54 ml/ 100 ml of tissue/ minute. Therefore, data 
appear to be reasonable, and in line with the range of expected values seen in other 
studies.   
 Within-day reliability for FBF measures at rest is reported in figures 5.1, 5.2 and 
5.3. Our data revealed that the SGP was highly reliable when measuring FBF within-
days, giving an r- value of .87, .93, and .97 for AI, VC, and VO .5-2, respectively. In fact 
our data were in line with others such as Sinoway et al., 1986, who reported a short-term 
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reliability coefficient for FBF measures such as hyperemic AI as r = .84.  Altenkirch et 
al., 1989, also found SGP to have good short-term reliability. Interestingly, Altenkirch, as 
well as our study, observed higher degree of variation in AI measures, which 























































Figure 5.3 Within-Day Reliability for VO Rest 
 
On the other hand, long-term measurement of FBF at rest was less reliable as 
shown in figures 5.4, 5.5 and 5.6. Results obtained in our study demonstrated long-term 
reliability for all FBF to be unacceptable, with reliability ranging from .51, .62, and .43 
for AI, VC, and VO .5-2 at rest. This trend is also consistent with Altenkirch et al., 1990, 
as well as Neubauer, et al., 2000, who found weak long-term reliability for resting 
measures taken at one-week intervals, with a reliability coefficient of r = .65, r = .52 and r 






















































Figure 5.6 Between-Day Reliability for VO Rest 
 
Additionally, all hyperemic FBF measures taken between-days are reported in 
figures 5.7, 5.8 and 5.9, revealing an r-value of .81, .56, and .63 for AI, VC, and VO .5-2, 
with only AI having acceptable reliability.  Altenkirch et al., 1990, found hyperemic 
measures taken between-days to be highly variable. Neubauer et al., 2000, also reported a 




























































Figure 5.9 Between-Day Reliability for Hyperemic VO 
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Altenkirch has suggested that the poor reliability seen in long-term measures may 
be due to biological factors such as electrolytes, hormones, and temperature that may 
contribute to the variability in these measures. Furthermore, the arterial side of the 
circulation seems to have larger degree of day-to-day variability at rest than the venous 
side, although it is unclear why. One possible explanation could be that the arterial side is 
more vasoactive, which would explain the differences in these measures. In contrast, 
reliability seen for hyperemic AI measures may be due, in part, to a build up of ischemic 
metabolites, which may provide a stimulus that is strong enough to override any factors 
that may contribute to the variation in these measures. This may contribute to the day-to-
day stability of hyperemic AI.  
Other factors, which may not be physiological, may explain some variation in the 
measurements. For example, Fehling, Arciero, MacPherson & Smith, 1999, found that 
variations in measures be also be due discrepancies in the acquisition of the waveform, 
reinforcing the necessity of following a strict set of testing guidelines when obtaining 
FBF measures. Altenkirch also suggests that the forearm itself may be poorly suited for 
intervention studies in cardiovascular control, since it is composed mostly of skin, which 
may make physiological factors more influential on FBF.  
Although hyperemic AI was found to have acceptable reliability, resting FBF 
measures may be more beneficial when studying disease. SGP may be more appropriate 
for serial measures taken within-days and may be problematic in longitudinal studies, due 
to the low degree of long-term reliability.  
Pearson correlations were done to determine the relationship of FBF with HR, 
age, gender and anthropometrical measures. Heart rate was found to be inversely 
 50 
associated with all VO indices. Although it is unclear, this association may be explained 
by the cardiopulmonary baroreceptor. This baroreceptor, located in the left ventricle, 
right atrium and large veins, is sensitive to changes in arterial pressure and may explain 
why those with lower VO indices also had higher heart rates. 
 Certain subject characteristics were also found to be significantly associated with 
venous measures. Height and arm length was found to be inversely associated with 
venous measures. This, according to Pousouille’s Law, could reflect the influence a 
vessel has on resistance to flow. This resistance to flow may be particular importance in a 
low-pressure circuit such as the venous system, since those with greater height and arm 
length had lower venous measures. 
As expected, VO was also inversely associated with age. This finding is 
consistent in other reports describing the relationship between VO and age. Studies 
relating the association between aging and endothelial dysfunction such as Gerhard, 
Roddy, Shelly and Creager, 1995, as well as Andrawis, Jones and Abernathy, 2000, have 
found an inverse association between age and vascular dysfunction. It was hypothesized 
in these studies that the age-related differences in blood flow was due to a decline in the 
release or activity of endothelium-derived nitric oxide. This loss of vasodilatory function 
and hence blood flow, is thought to contribute to the increased risk of atherosclerosis and 
thrombosis with adult aging (DeSouza et al., 2000).  
A stepwise regression indicated that vessel length was the strongest predictor for 
venous measures. The inclusion of other measures added less to the prediction equation. 
This is interesting when one considers the sudden death incidence among athletes being 
particularly high in basketball players. 
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We examined the area under the curves for venous outflow between the 0.5 sec 
and 2.0 sec time intervals in a subset of the study sample to assess the construct validity 
of the measure. Cramer’s method used to assess VO was compared to AUC technique 
and was found to be highly associated with VO at all time intervals. Additionally, the 
AUC technique was found to be highly reliable, which may make this technique a 
potentially more meaningful measure of VO.  
Although the venous occlusion plethysmography technique was found to have 
good short-term reliability, future studies should focus on the improvement of long-term 
reliability. Studies should also focus on venous indices as being a more meaningful 
measure of disease. Additionally, AUC may have potential importance as an assessment 
tool for VO, and therefore more attention should be given to the development this 
















 Aburto, T. K., Lajoie, C., & Morgan, K. G. (1993). Mechanism of signal 
transduction during alpha 2-adrenergic receptor-mediated contraction of vascular 
smoothe muscle. Circulation Research, 72, 778-85. 
 
 Aellig, H. W. (1994). Clinical pharmacology, physiology and pathophysiology 
of superficial veins. British Journal of Clinical Pharmacology, 38, 181-196 
 
 Allen, J. C., Kahn, A. M., & Navran, S. S. (1986). Na+-K+-ATPase in vascular 
smooth muscle. American Journal of Physiology, 250, C536-40. 
 
 Altenkirch, H. U., Fransson, L. & Koch, G. (1989). Assessment of arterial and 
venous circulation in upper and lower extremities by venous occlusion strain gauge 
plethysmography. Normal values and reproducibility. VASA, 18, 140-5. 
  
 Altenkirch, H. U., Koch, G. & Koralewski, H.E. (1990). Variability and 
reproducibility of arterial and venous circulation parameters in the forearm and calf 
measures at one-week intervals. VASA, 19, 21-5.     
 
 Altura, B. M., & Altura, B. T. (1984). Interactions of Mg and K on blood 
vessels-Aspects in view of hypertension. Magnesium, 3, 175-194.  
 
 Ando, S., Imaizumi, T., Harada, S., Hirooka, Y., & Takeshita, A. (1992).  
Atrial natriuretic peptide increases human capillary filtration and venous 
distensibility. Journal of Hypertension, 10, 451-7. 
 
 Andrawis, N., Jones, D.S. & Abernathy, D.R. (2000).  Aging is associated with 
endothelial dysfunction in the human forearm vasculature. Journal of American 
Geriatric Society, 48, 193-198.  
 
 Archie, J. P., & Green, J. J. (1990). Saphenous vein rupture pressure, rupture 
stress, and carotid endarterectomy vein patch reconstruction. Surgery, 107, 389-396. 
 
 Arner, M., & Hogestatt, E. D. (1991). Endothelium-dependent relaxation and 
effects of prostacyclin, endothelium, and platelet-activating factor in human hand 
veins and arteries. Acta Physiologica Scandinavia, 142, 165-172. 
 
 Barber, D. A., Wang, X., Glovickzi, P. & Miller, V. M. (1997). 
Characterization of endothelin receptors in human varicose veins. Journal of Vascular 
Surgery, 26, 61-9.  
 
 Barker, J. E., Anderson, J., Treasure, T. & Piper, P. J. (1994). Influence of 
endothelium and surgical preparation on responses of human saphenous vein and 
   
internal thoracic artery to angiotensin II. British Journal of Clinical Pharmacology, 
38, 57-62. 
 
 Baron, A., Loirand, G., Pacaud, P., Mironneau, C., & Mironneau, J. (1993). 
Dual effect of thrombin on voltage-dependent Ca2+-activated Cl- current in rat 
vascular smooth muscle cells. Circulation Research, 72, 1317-25. 
 
 Bax, W. A., Bos, E. & Saxena, R. P. (1993). Heterogeneity of 
endothelin\sarafotoxin receptors mediating contraction of the human isolated 
saphenous vein. European Journal of Pharmacology, 239, 267-8. 
 
 Beech, D. J., & Bolton, T. B. (1989). Two components of potassium current 
activated by depolarization of single smoothe muscle cells from the rabbit portal vein. 
Journal Physiology London,  418, 293-9. 
 
 Bevan, J. A., & Joyce, E. H. (1990). Saline infusion into lumen of resistance 
artery and small veins causes contraction. American Journal of Physiology, 259, H23-
28. 
 
 Bevan, J. A.  & Siegel, G. (1991). Blood vessel matrix flow sensor. Evidence 
and speculation. Blood Vessels, 28, 552-556. 
  
 Bevan, J. A., & Joyce, E. H. (1992). Comparable sensitivity of flow 
contraction and relaxation to Na reduction may reflect flow-sensor characteristics. 
American Journal of Physiology, 263, H182-87. 
 
 Bevan, J. A., & Joyce, E. H. (1993). Calcium dependence of flow-induced 
dilation. Cooperative interaction with sodium. Hypertension Dallas, 21, 16-21. 
 
  Bienvenu, K., & Granger, D. N. (1992). Molecular determinants of shear rate-
dependent leukocyte adhesion in postcapillary venules. American Journal of 
Physiology, 264, H1504-8. 
 
 Blochl-Daum, B., Schuller-Petrovic, S., Woltz, M., Korn, A., Bohler, K. & 
Eichler, H. (1991). Primary defect in alpha-adrenergic responsiveness in patients with 
varicose veins. Pharmacodynamics and Drug Action, 49, 49-52. 
 
 Bodelsson, M., Tornebrandt, K. Bertilsson, I. L., & Arneklo-Nobin, B. (1992). 
Heterogeneity of contractile 5-HT receptors in human hand veins. European Journal 
of Pharmacology, 219, 455-60. 
 
 Bretag, H. A. (1987). Muscle chloride channels. Physiological Reviews, 67, 
618-724. 
  
 54  
   
 Brock, T. A., Brugnara, C., Canessa, M., & Gimbrone, M. A. (1986). 
Bradykinin and vasopressin stimulate Na2+-K+-Cl- cotransport in cultured endothelial 
cells. American Journal of Physiology, 250, C888-95. 
 
 Brunkwall, J. S., Stanley, J. C., Kresowik, T. F., Graham, L. M., Burkel, W. E. 
& Berqvist, D. (1989). Prostanoid release from ex vivo perfused canine arteries and 
veins: Effects of prolonged perfusion, intermittent perfusion, as well as exposure to 
exogenous arachidonic acid, thrombin and bradykinin. Thrombosis Haemostasis, 62, 
1034-39.  
 
 Buga, G. M., Gold, M. E., Wood, K. S., Chaudhuri, G., & Ignarro, L. J. 
(1989). Endothelium-derived nitric oxide relaxes nonvascular smooth muscle. 
European Journal of Physiology, 161, 61-72. 
 
 Chiavarelli, M., Fabi, F., Stati, T., Chiavarelli, R., & Del Basso, P. (1992). 
Effects of cardioplegic solution and their components on human saphenous vein 
contractility. Annals in Thoracic Surgery, 53, 455-59. 
 
 Corbally, M. T., & Brennan, M. F. (1990). Non-invasive measurement of 
regional blood flow in man. American Journal of Surgery, 2, 313-21.  
 
 Cramer, M., Langlois, Y., Beach, K., Martin, D., and Strandness, D. E., Jr. 
(1983). Standardization of venous outflow measurements by strain gauge 
plethysmography in normal subjects. Bruit VII, 33-39. 
 
 Dachman, D., Ford, G. A., Blaschke, T. F., & Hoffman, B., B. (1993). 
Mechanism of bradykinin-induced venodilation in human. Journal of Cardiovascular 
Pharmacology, 21, 241-8. 
 
 Daly, R. N., Roberts, M. I., Ruffolo, R. R., & Hieble, J. P. (1988). The role of 
neuropeptide Y in vascular sympathetic neurotransmission may be enhanced in 
hypertension. Hypertension, 6, S535-8.  
 
 Davis, M. J., Donovitz, J. A., & Hood, J. D. (1992). Stretch-activated single-
channel and whole cells currents in vascular smooth muscle cells. American Journal 
of Physiology, 262, C1083-88. 
 
 DeSouza, C., Shapiro, L.F., Clevenger, C.M., Dinenno, F.A., Monahan, K.D., 
Tanaka, H. & Seals, D.R. (2000). Regular aerobic exercise prevents and restores age-
related declines in endothelium-dependent vasodilation in healthy men. Circulation, 
102, 1351-64.    
 
 Eldor, A., Hoover, E. L., Pett, Jr., S. B., Gay, Jr., W. A., Alonso, D. R. & 
Weksler, B. B. (1991). Prostacyclin production by arterialized autogenous venous 
grafts in dogs. Prostaglandins, 22, 485-499. 
 
 55  
   
 Escobales, N., Longo, E., Cragoe, E. J., Danthuluri, N. R., & Brock, T. (1990). 
Osmotic activation of Na2+-H+ exchange in human endothelial cells. American 
Journal of Physiology, 259, C640-6.  
 
 Faber, J. E., Gettes, D. R., & Gianturco, D. P. (1988).  Microvascular effects of 
atrial natriuretic peptide factor. Interaction with alpha-1 and alpha-2 adrenoreceptors. 
Circulation Research, 63, 415-28. 
 
 Falcone, J. C., & Bohlen, H. G. (1990). EDRF from rat intestine and skeletal 
muscle venules causes dilation of arterioles. American Journal of Physiology, 258, 
H515-23. 
  
 Fehling, P. C., Arciero, P. J., MacPherson, C. J. & Smith, D. L. (1999). 
Reproducibility of resting peripheral blood flow using strain gauge plethysmography. 
International Journal of Sports Medicine, 20, 555-559.    
 
 Figueroa, R., Omar, H. A., Tejani, N., & Wolin, M. S. (1993). Gestational 
diabetes alters human placental vascular responses to changes in oxygen tension. 
American Journal of Obstetrics and Gynecology, 168, 1616-22. 
 
 Flavahan, N. A. (1991). The role of vascular alpha2-adrenoreceptors as 
cutaneous thermosensors. News in Physiological Science, 6, 251-55.  
 
 Fried, G. & Samuelson, U. (1991). Endothelin and neuropeptide Y are 
vasoconstrictors in human uterine blood vessels. American Journal of Obstetrics and 
Gynecology, 164, 1330-36.  
 
 Fung, Y. C., & Liu, S. Q. (1992). Strain distribution in small blood vessels 
with zero-stress state taken in consideration. American Journal of Physiology, 262, 
H544-52. 
 
 Gascho, J. A., Fanelli, C., & Zelis, R. (1989). Aging reduces venous 
distensibility and the venodilatory response to nitroglycerin in normal subjects. 
American Journal of Cardiology, 63, 1267-70.  
 
 Gerhard, M., Roddy, M., Creager, S.J. & Creager, M.A. (1995). Aging 
progressively impairs endothelium-dependent vasodilation in forearm resistance 
vessels of humans. Hypertension, 27, 849-53.     
 
 Gizdulich, P. and Michelutti, M. (1983). Strain gauge venous occlusion 
plethysmography: Evidence of a trend in repeated blood flow measurements. 
Methods in Informative Medicine, 3, 204-209.  
 
 Glick, M.R., Gehman, J.D., and Gascho, J. A. (1993). Endothelium-derived 
nitric oxide reduces baseline venous tone in awake instrumented rats. American 
Journal of Physiology, 265, H47-51. 
 56  
   
 
 Gothert, M., Molderings, G. J., Fink, M., & Schlicker, E. (1991). 
Heterogeneity of presynaptic serotonin receptors on sympathetic neurons in blood 
vessels. Blood Vessels, 28, 11-18. 
  
 Greenberg, S. S., Diecke, F. P. J., Peevy, K., & Tanaka, T. P. (1990). Release 
of norepinephrine from adrenergic nerve endings of blood vessels is modulated by 
endothelium-derived relaxing factor. American Journal of Hypertension, 3, 211-18. 
 
 Hakim, T. S., Grunstein, M. M., & Michael, R. P. (1992). Opiate action in the 
pulmonary circulation. Pulmonary Pharmacology, 5, 159-65. 
 
 Hardebo, J. E., Kahrstrom, J., Owman, C., & Salford, L. G. (1987). Vasomotor 
effects of neurotransmitters and modulators on isolated human pial veins. Journal of 
Cerebral Blood Flow and Metabolism, 7, 612-18.  
 
 Haegerstrand, A., Dalsgaard, C. J., Jonzon, B., Larsson, O. & Nilsson, J. 
(1990). Calcitonin gene-related peptide stimulates proliferation of human endothelial 
cells. Proceedings in National Academy of Sciences, 87, 3299-03.  
 
 Hellstrand, P., Jorup, C., & Lydrup, M. L. (1984). O2 consumption, aerobic 
glycolysis and tissue phosphagen content during activation of the Na+/K+ pump in 
rat portal vein. European Journal of Physiology, 401, 119-24. 
 
 Henrion, D., Klaagen, A., & Bevan, J. A. (1992). Extracellular sodium 
modulates flow and stretch-induced constriction in opposite directions (Abstract). 
FASEB J, 6, A1545. 
  
 Hermsmeyer, K. (1991). Differences in calcium channels in vascular muscle 
hypertension. American Journal of Hypertension, 4, 412S-15S. 
 
 Hill, S. J. (1991). Histamine receptors and interactions between second 
messenger transduction systems. Agents and Actions, 33, 145-59. 
 
 Hokanson, E., Sumner, D. S. & Strandness, D. E. Jr. (1999). An electrically 
calibrated plethysmograph for direct measurement of limb flow. IEEE Transactions 
on Biomedical Engineering, 22, 25-29.  
 
 Honig, C. R., Gayeski, T. E., Clark, A., & Clark, P. A. (1991). Arteriovenous 
oxygen diffusion shunt is negligible in resting and working gracilis muscles. 
American Journal of Physiology, 261, H2031-43.  
 
 House, S. D. & Johnson, P. C. (1986). Miscrovascular pressure in venules of 
skeletal muscle during arterial pressure reduction. American Journal of Physiology, 
250, H828-37. 
  
 57  
   
 Ibrahim, S., MacPherson, D. R., and Goldhaber, S. Z. (1995). Chronic venous 
insufficiency: mechanisms And management. American Heart Journal, 7, 856-860. 
 
 Ikenouchi, H., Iizuka, M., Sato, H., Momomura, S., Serizawa, T. & Sugimoto, 
T. (1990). Forearm venous distensibility in relation to severity of symptoms and 
hemodynamic Data in patients with congestive heart failure. Japanese Heart Journal, 
17, 34-39.   
 
 Johnson, P. C. (1986). Autoregulation of blood flow. A brief review. 
Circulation Research, 59, 483-495. 
 
 Kent, K. C., Collins, C. J., Schwerin, F. T., Raydouwel-Hury, M. K., & Ware, 
J. A. (1993). Identification of functional PGH2/TxA2 receptors on human endothelial 
cells. Circulation Research, 72, 958-65. 
 
 Kobari, M., Gototh, F., & Fukuuchi, Y. (1985). Effects of (D-Met2, Pro5)-
enkephalinamide and naloxone on pial vessels in cats. Blood Flow Metabolism, 5, 34-
9. 
 
 Kobayashi, S., Gong, M. C., Somilyo, A. V., & Somilyo, A. P. (1991).  Ca2+ 
channel blockers distinguished between G protein-coupled pharmacomechanical 
Ca2+ release and Ca2+ sensitization. American Journal of Physiology, 260, C364 -
70. 
 
 LeJemtel, T. H., Katz, S., Jondeau, C., & Solomon, S. (1992). Critical analysis 
of methods for assessing regional blood flow and their reliability in clinical medicine. 
Chest, 8, 219S-222S.  
 
 Leppaluoto, J., & Ruskoaho, H. (1992). Endothelin peptides: biological 
activities, cellular signaling and clinical significance. Annals in Medicine, 24, 153-61. 
 
 Li, Q., Feenstra, M., Pfaffendorf, M., Eijsman, L. & van Zwieten, P. A. (1996). 
Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated 
saphenous vein. Journal of Cardiovascular Physiology, 29, 451-6. 
 
 Lowell, R. C., Glovickzi, P. & Miller, V. M. (1992). In vitro evaluation of 
endothelial and smoothe muscle function of primary varicose veins. Journal of 
Vascular Surgery, 16, 679-86. 
 
 Luu, T. N., Chester, A. H., O’Neil, G. S., Tadjkarimi, S., & Yacoub, M. H. 
(1992). Effects of vasoactive neuropeptides on human saphenous vein. British Heart 




 58  
   
Luu, T. N., Dashwood, M. R., Chester, A. H., Tadjkarimi, S., & Yacoub, M. H. 
(1993). Action of vasoactive intestinal peptide and distribution of its binding sites in 
vessels used for coronary artery bypass grafts. American Journal of Cardiology, 71, 
1278-82. 
 
 Malmqvist, U., Arner, A., & Uvelius, B. (1991). Lactate dehydrogenase 
activity and isoform distribution in normal and hypertrophic smoothe muscle tissue 
from the rat. Pfluegers Archives, 419, 230-34. 
 
 
 Marieb, E. M. (1992). Human Anatomy And Physiology, 2nd ed., (pp. 638-
639). Redwood City, CA. The Benjamin\Cummings Publishing Co. 
 
 Martin, D. S., & McNeil, J. R. (1991). Whole body vascular capacitance 
response to vasopressin is mediated by autonomic function. American Journal of 
Physiology, 261, H493-9.  
  
 Masaki, T., Kimura, S., Yanagisawa, M., & Goto, K. (1991). Molecular and 
cellular mechanism of endothelin regulation. Circulation, 84, 1457-68. 
 
 Mathie, R. T., Alexander, B., Ralevic, V., & Burnstock, G. (1991). Adenosine-
mediated dilatation of the rabbit hepatic arterial bed is mediated by alpha2 
purinoreceptors. British Journal of Pharmacology, 103, 1103-7. 
  
 McKardle, W. D., Katch, F. I., and Katch, V. L. (1996). Exercise Physiology, 
4th ed., (pp. 272-274). Baltimore, Maryland: Williams & Wilkins. 
 
 Mellander, S., Anderson, P. O., Afzelius, L. E., & Hellerstrand, P. (1982). 
Neural beta-adrenergic dilatation of the facial vein in man. Acta Physiologica 
Scandinavia, 114, 393-99. 
 
 Mizuno, K., Nimura, S., Tani, S. M., Haga, H., Inagami, T., & Fukuchii, S. 
(1991). Direct proof for local generation and release of angiotensin II in peripheral 
human vascular tissue. American Journal of Physiology, 4, 67S-72S. 
  
 Moncada, S., Palmer, R. M. J., & Higgs, E. A. (1991). Nitric oxide. 
Physiology, pathophysiology, and pharmacology. Pharmacological Reviews, 43, 109-
42. 
  
 Monos, E., Berczi, V., and Nadasy, G. (1995). Local control of veins: 
biomechanical, metabolic, and humoral aspects. Physiological Reviews, 75, 611-665. 
 
 Mortensen, J. D., Talbot, S. & Burkart, J. A. (1990). Cross-sectional internal 
diameters of human cervical and femoral blood vessels. Relationship to subject’s sex, 
age, and body size. Anatomy Research, 226, 115-24.   
  
 59  
   
 Nantel, F., Rouissi, N., Rhaleb, N. E., Dion, S., Drapeau, G., & Regoli, D. 
(1990). The rabbit jugular vein is a contractile NK-1 receptor system. European 
Journal of Pharmacology, 179, 457-62. 
  
 Naruse, K., & Sokabe, M. (1993). Involvement of stretch-activated ion 
channels in Ca2+ mobilization to mechanical stretch in endothelial cells. American 
Journal of Physiology, 264, C1037-44. 
  
 Neubauer, J., Bieniaszewski, L., Kruszewski, P., Swierblewski, E., Juzwa, W., 
Krupa-Wojciechowska, B. (2000). Assessment of plethysmographic indices 
repeatability according to body position, choice of forearm and method of 
measurements. American Journal of Physiology, 3, 575-582.  
 
 Onohara, T., Okadome, K., Yamamura, S., Komori, K., Ishii, T., Odashiro, T., 
& Sugimachi, K. (1993). Impaired endothelial prostacyclin production of the canine 
vein graft in a poor distal runoff limb. Surgery, 113, 700-8.  
  
 Pallares, L. C. M., Deane, C. R., Baudouin, S. V., and Evans, T. W. (1994). 
Strain gauge plethysmography and doppler ultrasound in the measurement of limb 
blood flow. European Journal of Clinical Investigation, 24, 279-286. 
 
 Pan, HYM, Hoffman, B.B., Pershe, R.A. & Blaschke, T. F. (1986). Decline in 
beta adrenergic receptor-mediated vascular relaxation with aging in man. Journal of 
Pharmacology and Experimental Therapeutics, 239, 802-807. 
 
 Papageorgiou, P., & Morgan, K. G. (1990). The nuclear-cytoplasmic Ca2+ 
gradient in single mammalian vascular smoothe muscle cells. Proceedings in 
Sociology and Experimental Biological Medicine, 193, 331-34. 
  
 Queroy, A., & Verdetti, J. (1992). Cooperative gating of chloride channel 
subunits in endothelial cells. Biochemistry and Biophysiologica Acta, 1108, 159-68.  
 
 Raya, T. E., Gay, R. G., & Goldman, S. (1990). Selective vasopressin 
inhibition in rats with heart failure decreases afterload and results in venodilation. 
Journal of Pharmacology Experimental Therapeutics, 255, 1015-1020.  
 
 Regoli, D., Dion, S., Rhaleb, N. E., Rouissi, N., Tousignant, C., & Jukic, D. 
(1989). Selective agonists for receptors of substance P and related neurokinins. 
Biopolymers,  28, 81-90. 
  
 Rice, T. L. (1989). Treatment of esophageal varices. Clinical Pharmacology, 8, 
122-31. 
 
 Rizzi, A., Quaglio, D., Vasquez, G., Mascoli, F., Amadesi, S., Calo, G., 
Regoli, D., and Zamboni, P. (1998). Effects of vasoactive agents in healthy and 
diseased human saphenous veins. Journal of Vascular Surgery, 7, 855-861. 
 60  
   
 
 Romano, S., & Gizdulich, P. (1980). Reproducibility of strain gauge venous 
occlusion plethysmography in long run measurements in man. Methods and Findings 
in Experimental Clinical Pharmacology, 35, 83-87. 
 
  Rongen, G. A., Smits, P. & Thien, T. (1992). Endothelium and the 
regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, 
pathophysiology and clinical implications. Netherlands Journal of Medicine, 44, 26-
35. 
 
 Rubanyi, G. M. & Vanhoutte, P. M. (1988). Heterogeneity of endothelium-
dependent responses to acetylcholine in canine femoral arteries and veins. Blood 
Vessels, 25, 75-81. 
 
 Sansivero, G. E. (1998). Venous anatomy and physiology. Journal of 
Intravenous Nursing, 6, S107-14.  
 
 Sato, H., Ikenouchi, H., Aoyagi, T., Matsui, H., Mochizuki, T., Momomura, S., 
Serizawa, T., Iizuki, M. & Sugimoto, T. (1989). Pathophysiology and evaluation of 
congestive heart failure on the basis of venous characteristics. Japanese Circulation 
Journal, 23, 141-145. 
 
 Schina, M. J., Neumyer, M. M., Healy, D. A., Atnip, R. G., & Thiele, B. L. 
(1993). Influence of age on venous physiologic parameters. Journal of Vascular 
Surgery, 7, 749-752. 
 
 Simon, G. (1978). Venous changes in renal hypertensive rats: role of humoral 
factors. Blood Vessels, 15, 311-21. 
 
 Simon, G. (1990). Increased vascular wall sodium in hypertension. Where did 
it come from? How did it get there, and what does it do there? Clinical Science, 78, 
533-40.  
 
 Sinoway, L. I., Musch, T. I., Minotti, J. R., and Zelis, R. (1986). Enhanced 
maximal metabolic vasodilation in the dominant forearms of tennis players. Journal 
of Applied Physiology,  61, 673-678. 
 
 Sjoberg, T., Andersson, K. E., Norgren, L., & Steen, S. (1987). Comparative 
effects of some calcium-channel blockers on human peripheral arteries and veins. 
Acta Physiologica Scandinavia, 130, 419-27. 
  
 Soloviev, A. I., & Basilyuk, O. V. (1993). Evidence for decrease in 
myofilament responsiveness to Ca2+ during hypoxia in spontaneously active vascular 
smoothe muscle in rats. Experimental Physiology, 78, 395-402. 
 
 61  
   
 Sudhir, K., Angus, J. A., Esler, M. D., Jennings, G. L., Lambert, G. W., & 
Korner, P. I. (1990). Altered venous responses to vasoconstrictor agonists and nerve 
stimulation in human primary hypertension. Clinical Experiments in Hypertension, 
12, 1119-28. 
 
 Sung, C. P., Arleth, A. J., & Feuerstein, G. Z. (1991). Neuropeptide Y 
upregulates the adhesiveness of human endothelial cells for leukocytes. Circulation 
Research, 68, 314-18.  
  
 Sumner, A., Zelis, R., Bennet, M., Gascho, J. A. (1989). Effect of sympathetic-
induced venoconstriction in normal subjects. American Journal of Cardiology, 63, 
973-976. 
 
 Supiano, M. A., Hogikyan, R. V., Stoltz, A. M., Orstan, N., & Halter, J. B. 
(1991). Regulation of venous alpha-adrenergic responses in older  
humans. American Journal of Physiology, Endocrinology and Metabolism, 260, 
E599-E607. 
 
 Szabo, C., Berczi, V., Schneider, F., Kovach, A. G. B. & Monos, E. (1992).  
Role of endothelium in the response of the vein wall to magnesium withdrawal. 
Pfluegers Archives, 420, 140-5.  
  
 Takata, S., Fukase, M., Takagi, Y., Tokunaga, O., & Fujita, T. (1990). Rapid 
Ca2+ refilling system of intracellular stores in human vascular endothelial cells. 
Biochemistry and Biophysiology in Research Community, 167, 933-40. 
 
 Thulesius, O., Ugaily-Thulesius, L., Gjores, J. E. & Neglen, P. (1988). The 
varicose saphenous vein, functional and ultrastructural studies, with special reference 
to smooth muscle. Phlebology, 3, 89-95. 
 
 Tsujimoto, G., Lee, CH. & Hoffman, B. B. (1986). Age-related decrease in 
beta adrenergic-mediated vascular smoothe muscle relaxation. Journal of 
Pharmacology and Experimental Therapeutics, 239, 411-415.   
 
 Tsukahara, H., Gordienko, D. V., & Goligorsky, M. S. (1993). Continuous 
monitoring of nitric oxide release from human umbilical vein endothelial cells. 
Biochemistry and Biophysiology Research Community, 193, 722-29.  
  
 Tsuru, H., Kohno, S., Iwata, M., & Shigel, T. (1987). Characterization of 
histamine receptors in isolated rabbit veins. Journal of Pharmacology and 
Experimental Therapeutics, 243, 696-702. 
 
 Wali, F. A., Greenridge, E., & Tugwell, A. C. (1988). Effect of varapamil on 
the contraction produced by high potassium and by noradrenaline in human isolated 
saphenous vein. Acta Physiologica Hungary, 72, 115-21. 
 
 62  
   
 Walsh, J. A., Hyman, Ch. & Maronde, R. F. (1969). Venous distensibility in 
essential hypertension. Cardiovascular Research, 3, 338-349.   
 
 Webb, D. J., Benjamin, N., Cockcroft, J. R., & Collier, J. G. (1989). 
Augmentation of sympathetic venoconstriction by angiotensin II in human dorsal 
hand veins. American Journal of Hypertension, 2, 721-23. 
 
 Wecht, J. M., De Meersman, R. E., Weir, P. J., Bauman, A. W. & Grimm, D. 
R. (2000). Effects of autonomic disruption and inactivity on venous vascular function. 
American Journal of Physiology of Heart Circulation Physiology, 278, H515-H520. 
 
 Woldhuis, B., Tangelder, G. J., Slaaf, D. W., & Reneman, R. S. (1992). 
Concentration profile of blood platelets differs in arterioles and venules. American 
Journal of Physiology, 262, H1217-23.   
 
 Wu, N. W., Jalkanen, S., Streeter, P. R. & Butcher, E. C. (1988). Evolutionary 
conservation of tissue-specific lymphocyte-endothelial cell recognition mechanisms 
involved in lymphocyte homing. Journal of Cellular Biology, 107, 1845-51. 
  
 Yanagisawa, M., Kurhara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, 
Y., Yazaki, Y., Goto, K., & Masaki, T. (1988). A novel potent vasoconstrictor peptide 
produced by vascular endothelial cells. Nature London, 332, 411-15. 
 
 Yang, Z., Von Segesser, L., Bauer, E., Stulz, P., Turina, M., & Luscher, T. F. 
(1991). Different activation of the endothelial l-arginine and cyclooxygenase pathway 
in the human internal mammary artery and vein. Circulation Research, 68, 52-60. 
  
 Zhang, A. Carella, A., Altura, B. T., & Altura, B. M. (1991). Interactions of 
magnesium and chloride ions on tone and contractility of vascular smoothe muscle. 














 63  





Jennifer P. Ortego was born on February 13, 1974, in Ville Platte, Louisiana, to 
Chris and Hedy Pitre. She was raised in Eunice, Louisiana, where she attended East 
Elementary, Central Middle, Eunice Junior High and Eunice High School. Jennifer then 
attended Louisiana State University at Eunice, and then transferred to Louisiana State 
University at Baton Rouge, where she graduated in May of the year 1998 and received 
the degree of Bachelor of Science in kinesiology, with a concentration in fitness studies. 
She entered the graduate program at Louisiana State University in 1999, and expects to 
be awarded the degree of Master of Science in kinesiology in May 2002. 
 In January of 2002, Jennifer plans to pursue a career in the medical field. Jennifer 





 64  
